BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thia KT, Loftus EV, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103:3167-3182. [PMID: 19086963 DOI: 10.1111/j.1572-0241.2008.02158.x] [Cited by in Crossref: 337] [Cited by in F6Publishing: 339] [Article Influence: 28.1] [Reference Citation Analysis]
Number Citing Articles
1 Hirano A, Yamazaki K, Umeno J, Ashikawa K, Aoki M, Matsumoto T, Nakamura S, Ninomiya T, Matsui T, Hirai F, Kawaguchi T, Takazoe M, Tanaka H, Motoya S, Kiyohara Y, Kitazono T, Nakamura Y, Kamatani N, Kubo M. Association study of 71 European Crohn's disease susceptibility loci in a Japanese population. Inflamm Bowel Dis. 2013;19:526-533. [PMID: 23388546 DOI: 10.1097/mib.0b013e31828075e7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
2 Hendy P, Hart A, Irving P. Anti-TNF drug and antidrug antibody level monitoring in IBD: a practical guide. Frontline Gastroenterol 2016;7:122-8. [PMID: 28839846 DOI: 10.1136/flgastro-2014-100527] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
3 Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, Willett WC, Richter JM, Chan AT. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut 2014;63:776-84. [PMID: 23828881 DOI: 10.1136/gutjnl-2013-305304] [Cited by in Crossref: 225] [Cited by in F6Publishing: 194] [Article Influence: 28.1] [Reference Citation Analysis]
4 Luther J, Owyang SY, Takeuchi T, Cole TS, Zhang M, Liu M, Erb-Downward J, Rubenstein JH, Chen CC, Pierzchala AV. Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis. Gut. 2011;60:1479-1486. [PMID: 21471567 DOI: 10.1136/gut.2010.220087] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 6.1] [Reference Citation Analysis]
5 Zhang S, Zhong B, Chao K, Xiao Y, Cui Y, Gao X, Chen B, He Y, Hu P, Chen M. Role of Helicobacter species in Chinese patients with inflammatory bowel disease. J Clin Microbiol. 2011;49:1987-1989. [PMID: 21346040 DOI: 10.1128/jcm.02630-10] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
6 Ko SJ, Bu Y, Bae J, Bang YM, Kim J, Lee H, Beom-Joon L, Hyun YH, Park JW. Protective effect of Laminaria japonica with probiotics on murine colitis. Mediators Inflamm 2014;2014:417814. [PMID: 24948848 DOI: 10.1155/2014/417814] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
7 Ng SC, Hirai HW, Tsoi KK, Wong SH, Chan FK, Sung JJ, Wu JC. Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn's disease in Asians. J Gastroenterol Hepatol. 2014;29:1664-1670. [PMID: 24910240 DOI: 10.1111/jgh.12645] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
8 Ng SC. Changing Epidemiology and Future Challenges of Inflammatory Bowel Disease in Asia. Intest Res 2010;8:1. [DOI: 10.5217/ir.2010.8.1.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Ng SC. Emerging leadership lecture: Inflammatory bowel disease in Asia: Emergence of a “Western” disease: IBD in Asia. J Gastroenterol Hepatol 2015;30:440-5. [DOI: 10.1111/jgh.12859] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 10.0] [Reference Citation Analysis]
10 Jackson B, De Cruz P. Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis. Expert Rev Gastroenterol Hepatol 2018;12:1079-100. [PMID: 30284911 DOI: 10.1080/17474124.2018.1530109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Habib I, Mazulis A, Roginsky G, Ehrenpreis ED. Nonsteroidal Anti-inflammatory Drugs and Inflammatory Bowel Disease: Pathophysiology and Clinical Associations. Inflammatory Bowel Diseases 2014;20:2493-502. [DOI: 10.1097/mib.0000000000000165] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Hosoe N, Matsuoka K, Naganuma M, Ida Y, Ishibashi Y, Kimura K, Yoneno K, Usui S, Kashiwagi K, Hisamatsu T, Inoue N, Kanai T, Imaeda H, Ogata H, Hibi T. Applicability of second-generation colon capsule endoscope to ulcerative colitis: A clinical feasibility study: Applicability of colon capsule endoscope. J Gastroenterol Hepatol 2013;28:1174-9. [DOI: 10.1111/jgh.12203] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
13 Jung S, Ye BD, Lee HS, Baek J, Kim G, Park D, Park SH, Yang SK, Han B, Liu J, Song K. Identification of three novel susceptibility loci for inflammatory bowel disease in Koreans in an extended genome-wide association study. J Crohns Colitis 2021:jjab060. [PMID: 33853113 DOI: 10.1093/ecco-jcc/jjab060] [Reference Citation Analysis]
14 Cholapranee A, Ananthakrishnan AN. Environmental Hygiene and Risk of Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis. Inflamm Bowel Dis 2016;22:2191-9. [PMID: 27482977 DOI: 10.1097/MIB.0000000000000852] [Cited by in Crossref: 37] [Cited by in F6Publishing: 18] [Article Influence: 12.3] [Reference Citation Analysis]
15 Moon CM, Park DI, Kim ER, Kim Y, Lee CK, Lee S, Kim JH, Huh K, Jung S, Yoon SM, Song HJ, Jang HJ, Kim YS, Lee K, Shin JE. Clinical features and predictors of clinical outcomes in Korean patients with Crohn's disease: A Korean Association for the Study of Intestinal Diseases multicenter study: Clinical predictors of Korean Crohn's disease. J Gastroenterol Hepatol 2014;29:74-82. [DOI: 10.1111/jgh.12369] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
16 Spooren CE, Pierik MJ, Zeegers MP, Feskens EJ, Masclee AA, Jonkers DM. Review article: The association of diet with onset and relapse in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38:1172-1187. [PMID: 24118051 DOI: 10.1111/apt.12501] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
17 Yamamoto T. Risk factors for symptomatic recurrence after intestinal resection for Crohn's disease: a retrospective study in a Chinese population. J Gastrointest Surg. 2013;17:1540-1541. [PMID: 23609139 DOI: 10.1007/s11605-013-2203-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
18 Damas OM, Avalos DJ, Palacio AM, Gomez L, Quintero MA, Deshpande AR, Sussman DA, McCauley JL, Lopez J, Schwartz SJ, Abreu MT. Inflammatory bowel disease is presenting sooner after immigration in more recent US immigrants from Cuba. Aliment Pharmacol Ther 2017;46:303-9. [PMID: 28524546 DOI: 10.1111/apt.14145] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
19 Park S, Noh YH, Rha SY, Kim WH, Cheon JH. Institutional Board Review for Clinical Investigations on Inflammatory Bowel Diseases: A Single-Center Study. Intest Res 2015;13:274-81. [PMID: 26131003 DOI: 10.5217/ir.2015.13.3.274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Wada S, Sato K, Ohta R, Wada E, Bou Y, Fujiwara M, Kiyono T, Park EY, Aoi W, Takagi T, Naito Y, Yoshikawa T. Ingestion of Low Dose Pyroglutamyl Leucine Improves Dextran Sulfate Sodium-Induced Colitis and Intestinal Microbiota in Mice. J Agric Food Chem 2013;61:8807-13. [DOI: 10.1021/jf402515a] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
21 Hilmi I, Sunderesvaran K, Ananda V, Sarji SA, Arumugam K, Goh KL. Increased fracture risk and osteoporosis not associated with vitamin D levels in Malaysian patients with inflammatory bowel disease. J Clin Endocrinol Metab. 2013;98:2415-2421. [PMID: 23553858 DOI: 10.1210/jc.2013-1147] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
22 Imawana RA, Smith DR, Goodson ML. The relationship between inflammatory bowel disease and Helicobacter pylori across East Asian, European and Mediterranean countries: a meta-analysis. Ann Gastroenterol 2020;33:485-94. [PMID: 32879595 DOI: 10.20524/aog.2020.0507] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Ananthakrishnan AN. Environmental triggers for inflammatory bowel disease. Curr Gastroenterol Rep. 2013;15:302. [PMID: 23250702 DOI: 10.1007/s11894-012-0302-4] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 8.3] [Reference Citation Analysis]
24 Tsai MS, Chen HP, Hung CM, Lee PH, Lin CL, Kao CH. Hospitalization for Inflammatory Bowel Disease is Associated with Increased Risk of Breast Cancer: A Nationwide Cohort Study of an Asian Population. Ann Surg Oncol 2015;22:1996-2002. [PMID: 25354573 DOI: 10.1245/s10434-014-4198-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
25 Park JH, Nam HN, Lee JH, Hong J, Yi DY, Ryoo E, Jeon IS, Tchah H. Characteristics of Upper Gastrointestinal Tract Involvement in Korean Pediatric Crohn's Disease: A Multicenter Study. Pediatr Gastroenterol Hepatol Nutr 2017;20:227-35. [PMID: 29302504 DOI: 10.5223/pghn.2017.20.4.227] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
26 Martino JV, Van Limbergen J, Cahill LE. The Role of Carrageenan and Carboxymethylcellulose in the Development of Intestinal Inflammation. Front Pediatr 2017;5:96. [PMID: 28507982 DOI: 10.3389/fped.2017.00096] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 10.5] [Reference Citation Analysis]
27 Gearry RB, Irving PM. Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to? J Gastroenterol Hepatol 2009;24:1160-2. [PMID: 19682189 DOI: 10.1111/j.1440-1746.2009.05896.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
28 Lee HS, Park SH, Yang SK, Lee J, Soh JS, Lee S, Bae JH, Lee HJ, Yang DH, Kim KJ, Yea BD, Byeon JS, Myung SJ, Yoon YS, Yu CS, Kim JH. Long-term prognosis of ulcerative colitis and its temporal change between 1977 and 2013: a hospital-based cohort study from Korea. J Crohns Colitis. 2015;9:147-155. [PMID: 25518059 DOI: 10.1093/ecco-jcc/jju017] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 10.2] [Reference Citation Analysis]
29 Kashyap PC, Reigstad CS, Loftus EV Jr. Role of diet and gut microbiota in management of inflammatory bowel disease in an Asian migrant. J Allergy Clin Immunol 2013;132:250-250.e5. [PMID: 23810100 DOI: 10.1016/j.jaci.2013.05.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
30 Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN. Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies. Clin Gastroenterol Hepatol 2018;16:190-197.e11. [PMID: 28603049 DOI: 10.1016/j.cgh.2017.05.047] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
31 崔德军, 杨敏, 朱敏, 李宇. 幽门螺杆菌感染与克罗恩病的关系. 世界华人消化杂志 2013; 21(15): 1468-1472 [DOI: 10.11569/wcjd.v21.i15.1468] [Reference Citation Analysis]
32 Shen J, Mao AP, Zhu MM, Zhao P, Xu JJ, Zuo Z. Ulcerative Colitis Database: An Integrated Database and Toolkit for Gene Function and Medication Involved in Ulcerative Colitis. Inflamm Bowel Dis 2015;21:1872-82. [PMID: 26199991 DOI: 10.1097/MIB.0000000000000411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Xu L, Lochhead P, Ko Y, Claggett B, Leong RW, Ananthakrishnan AN. Systematic review with meta-analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;46:780-789. [PMID: 28892171 DOI: 10.1111/apt.14291] [Cited by in Crossref: 67] [Cited by in F6Publishing: 51] [Article Influence: 16.8] [Reference Citation Analysis]
34 Lee EJ, Moon JS, Ko JS, Yang HR, Jang JY, Kim JW, Lee KJ. Effect of the Baseline Vitamin D Level on Growth Outcome in Pediatric Crohn Disease. Pediatr Gastroenterol Hepatol Nutr 2017;20:41-6. [PMID: 28401055 DOI: 10.5223/pghn.2017.20.1.41] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Narula N, Wong ECL, Dehghan M, Mente A, Rangarajan S, Lanas F, Lopez-Jaramillo P, Rohatgi P, Lakshmi PVM, Varma RP, Orlandini A, Avezum A, Wielgosz A, Poirier P, Almadi MA, Altuntas Y, Ng KK, Chifamba J, Yeates K, Puoane T, Khatib R, Yusuf R, Boström KB, Zatonska K, Iqbal R, Weida L, Yibing Z, Sidong L, Dans A, Yusufali A, Mohammadifard N, Marshall JK, Moayyedi P, Reinisch W, Yusuf S. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ 2021;374:n1554. [PMID: 34261638 DOI: 10.1136/bmj.n1554] [Reference Citation Analysis]
36 Yoon JY, Shin JE, Park SH, Park DI, Cha JM. Disability due to Inflammatory Bowel Disease Is Correlated with Drug Compliance, Disease Activity, and Quality of Life. Gut Liver 2017;11:370-6. [PMID: 28208008 DOI: 10.5009/gnl16422] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
37 Chen B, Gao X, Zhong J, Ren J, Zhu X, Liu Z, Wu K, Kalabic J, Yu Z, Huang B, Kwatra N, Doan T, Robinson AM, Chen MH. Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn's disease: results from a randomized trial. Therap Adv Gastroenterol 2020;13:1756284820938960. [PMID: 32733600 DOI: 10.1177/1756284820938960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Nagar J, Ranade S, Kamath V, Singh S, Karunanithi P, Subramani S, Venkatesh K, Srivastava R, Dudhgaonkar S, Vikramadithyan RK. Therapeutic potential of chloroquine in a murine model of inflammatory bowel disease. Int Immunopharmacol 2014;21:328-35. [PMID: 24859061 DOI: 10.1016/j.intimp.2014.05.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
39 De AK, Sana S, Datta S, Mukherjee A. Protective efficacy of ursodeoxycholic acid nanoparticles in animal model of inflammatory bowel disease. J Microencapsul. 2014;31:725-737. [PMID: 24963957 DOI: 10.3109/02652048.2014.918666] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
40 Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, Che T, Zhang C. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens 2019;8:E126. [PMID: 31412603 DOI: 10.3390/pathogens8030126] [Cited by in Crossref: 127] [Cited by in F6Publishing: 113] [Article Influence: 63.5] [Reference Citation Analysis]
41 Rehman A, Rausch P, Wang J, Skieceviciene J, Kiudelis G, Bhagalia K, Amarapurkar D, Kupcinskas L, Schreiber S, Rosenstiel P, Baines JF, Ott S. Geographical patterns of the standing and active human gut microbiome in health and IBD. Gut 2016;65:238-48. [PMID: 25567118 DOI: 10.1136/gutjnl-2014-308341] [Cited by in Crossref: 82] [Cited by in F6Publishing: 80] [Article Influence: 13.7] [Reference Citation Analysis]
42 Nerich V, Monnet E, Weill A, Vallier N, Vanbockstael V, Auleley G, Balaire C, Dubost P, Rican S, Allemand H, Carbonnel F. Fine-scale geographic variations of inflammatory bowel disease in France: Correlation with socioeconomic and house equipment variables: . Inflammatory Bowel Diseases 2010;16:813-21. [DOI: 10.1002/ibd.21122] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
43 Wang K, Wu LY, Dou CZ, Guan X, Wu HG, Liu HR. Research Advance in Intestinal Mucosal Barrier and Pathogenesis of Crohn's Disease. Gastroenterol Res Pract 2016;2016:9686238. [PMID: 27651792 DOI: 10.1155/2016/9686238] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
44 Riansuwan W, Limsrivilai J. Current status of IBD and surgery of Crohn's disease in Thailand. Ann Gastroenterol Surg 2021;5:597-603. [PMID: 34585044 DOI: 10.1002/ags3.12470] [Reference Citation Analysis]
45 Miranda S, Roux ME. Acoustic stress induces long term severe intestinal inflammation in the mouse. Toxicol Lett 2017;280:1-9. [PMID: 28774831 DOI: 10.1016/j.toxlet.2017.07.898] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
46 Al-Mofarreh MA, Al-Mofleh IA. Emerging inflammatory bowel disease in saudi outpatients: a report of 693 cases. Saudi J Gastroenterol. 2013;19:16-22. [PMID: 23319033 DOI: 10.4103/1319-3767.105915] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
47 Lin HM, Helsby NA, Rowan DD, Ferguson LR. Using metabolomic analysis to understand inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:1021-1029. [PMID: 20629098 DOI: 10.1002/ibd.21426] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
48 Hoshina T, Sakurai T, Ichimura H, Ishiwata K, En S, Yamada T, Kwangyole L, Shimizu A, Hase K, Kanuka H. Safety and tolerability of medicinal parasite ova (Trichuris suis) in healthy Japanese volunteers: A randomized, double-blind, placebo-controlled trial. Parasitol Int 2021;85:102441. [PMID: 34425258 DOI: 10.1016/j.parint.2021.102441] [Reference Citation Analysis]
49 Ng SC, Chan FKL, Sung JJY. Review article: the role of non-biological drugs in refractory inflammatory bowel disease: Review: refractory inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2011;33:417-27. [DOI: 10.1111/j.1365-2036.2010.04541.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
50 Yi JM, Kim TO. Epigenetic alterations in inflammatory bowel disease and cancer. Intest Res. 2015;13:112-121. [PMID: 25931995 DOI: 10.5217/ir.2015.13.2.112] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
51 Latella G, Fiocchi C, Caprili R. News from the “5th International Meeting on Inflammatory Bowel Diseases” CAPRI 2010. J Crohns Colitis. 2010;4:690-702. [PMID: 21122584 DOI: 10.1016/j.crohns.2010.08.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
52 Park SH, Hwang SW, Kwak MS, Kim WS, Lee JM, Lee HS, Yang DH, Kim KJ, Ye BD, Byeon JS. Long-Term Outcomes of Infliximab Treatment in 582 Korean Patients with Crohn’s Disease: A Hospital-Based Cohort Study. Dig Dis Sci. 2016;61:2060-2067. [PMID: 26971089 DOI: 10.1007/s10620-016-4105-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
53 Choi YS, Kim DS, Lee JB, Kim JK, Jung HJ, Lee SD, Song KH, Lee DH, Kim MJ. Clinical Features of Tuberculous Versus Crohn's Anal Fistulas, in Korea. J Crohns Colitis 2015;9:1132-7. [PMID: 26374663 DOI: 10.1093/ecco-jcc/jjv164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Ali MN, Choijookhuu N, Takagi H, Srisowanna N, Nguyen Nhat Huynh M, Yamaguchi Y, Synn Oo P, Tin Htwe Kyaw M, Sato K, Yamaguchi R, Hishikawa Y. The HDAC Inhibitor, SAHA, Prevents Colonic Inflammation by Suppressing Pro-inflammatory Cytokines and Chemokines in DSS-induced Colitis. Acta Histochem Cytochem 2018;51:33-40. [PMID: 29622848 DOI: 10.1267/ahc.17033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
55 Studd C, Cameron G, Beswick L, Knight R, Hair C, McNeil J, Desmond P, Wilson J, Connell W, Bell S. Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia. J Gastroenterol Hepatol. 2016;31:81-86. [PMID: 26222770 DOI: 10.1111/jgh.13050] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
56 Chu HP, Logarajah V, Tan N, Phua KB. Paediatric inflammatory bowel disease in a multiracial Asian country. Singapore Med J. 2013;54:201-205. [PMID: 23624446 DOI: 10.11622/smedj.2013073] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
57 Holik D, Bezdan A, Marković M, Orkić Ž, Milostić-Srb A, Mikšić Š, Včev A. The Association between Drinking Water Quality and Inflammatory Bowel Disease-A Study in Eastern Croatia. Int J Environ Res Public Health 2020;17:E8495. [PMID: 33207850 DOI: 10.3390/ijerph17228495] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Yazısız V. Similarities and differences between Behçet's disease and Crohn's disease. World J Gastrointest Pathophysiol 2014; 5(3): 228-238 [PMID: 25133025 DOI: 10.4291/wjgp.v5.i3.228] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
59 Rahman EU, Gayam V, Garlapati P, Patel N, Farah F, El-Hamdani A, Khan A, Okhumale PI, Aronow WS, El-Hamdani M. Association of atrial fibrillation with outcomes in patients hospitalized with inflammatory bowel disease: an analysis of the National Inpatient Sample. Arch Med Sci Atheroscler Dis 2021;6:e40-7. [PMID: 34027213 DOI: 10.5114/amsad.2021.105256] [Reference Citation Analysis]
60 Wang YL, Fang M, Wang XM, Liu WY, Zheng YJ, Wu XB, Tao R. Proinflammatory effects and molecular mechanisms of interleukin-17 in intestinal epithelial cell line HT-29. World J Gastroenterol 2014; 20(47): 17924-17931 [PMID: 25548490 DOI: 10.3748/wjg.v20.i47.17924] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
61 Yoo YS, Cho OH, Cha KS. Disease-Related Knowledge and Information Needs Among Inflammatory Bowel Disease Patients in Korea. Gastroenterol Nurs 2015;38:455-63. [PMID: 25159269 DOI: 10.1097/SGA.0000000000000063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
62 Niriella MA, Liyanage IK, Kodisinghe SK, Silva APD, Rajapakshe N, Nanayakkara SD, Luke D, Silva T, Nawarathne M, Peiris RK, Kalubovila UP, Kumarasena SR, Dissanayake VHW, Jayasekara RW, de Silva HJ. Genetic associations of inflammatory bowel disease in a South Asian population. World J Clin Cases 2018; 6(15): 908-915 [PMID: 30568945 DOI: 10.12998/wjcc.v6.i15.908] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
63 Domislović V, Vranešić Bender D, Barišić A, Brinar M, Ljubas Kelečić D, Rotim C, Novosel M, Matašin M, Krznarić Ž. HIGH PREVALENCE OF UNTREATED AND UNDERTREATED VITAMIN D DEFICIENCY AND INSUFFICIENCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. Acta Clin Croat 2020;59:109-18. [PMID: 32724281 DOI: 10.20471/acc.2020.59.01.13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Ng SC, Zeng Z, Niewiadomski O, Tang W, Bell S, Kamm MA, Hu P, de Silva HJ, Niriella MA, Udara WS. Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia. Gastroenterology. 2016;150:86-95.e3; quiz e13-4. [PMID: 26385074 DOI: 10.1053/j.gastro.2015.09.005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 10.7] [Reference Citation Analysis]
65 Asada T, Nakayama G, Tanaka C, Kobayashi D, Ezaka K, Hattori N, Kanda M, Yamada S, Koike M, Kodera Y. Postoperative adalimumab maintenance therapy for Japanese patients with Crohn's disease: a single-center, single-arm phase II trial (CCOG-1107 study). Surg Today 2018;48:609-17. [PMID: 29476258 DOI: 10.1007/s00595-018-1634-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
66 Lim JW, Kim KJ, Ye BD, Byeon JS, Myung SJ, Yang SK, Kim JH. Enterovenous fistulization: A rare complication of Crohn’s disease. World J Gastroenterol 2011; 17(47): 5227-5230 [PMID: 22215949 DOI: 10.3748/wjg.v17.i47.5227] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
67 Lee HH, Bae JM, Lee B, Lee K, Wie JH, Kim JS, Cho Y, Jung S, Kim SW, Choi H, Choi M. Pregnancy outcomes in women with inflammatory bowel disease: a 10-year nationwide population-based cohort study. Aliment Pharmacol Ther 2020;51:861-9. [DOI: 10.1111/apt.15654] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
68 Kang EA, Chun J, Kim JH, Han K, Soh H, Park S, Hong SW, Moon JM, Lee J, Lee HJ, Park JB, Im JP, Kim JS. Periodontitis combined with smoking increases risk of the ulcerative colitis: A national cohort study. World J Gastroenterol 2020; 26(37): 5661-5672 [PMID: 33088159 DOI: 10.3748/wjg.v26.i37.5661] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
69 Chou JW, Lai HC, Chang CH, Cheng KS, Feng CL, Chen TW. Epidemiology and Clinical Outcomes of Inflammatory Bowel Disease: A Hospital-Based Study in Central Taiwan. Gastroenterol Res Pract. 2019;2019:4175923. [PMID: 31312216 DOI: 10.1155/2019/4175923] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
70 Kedia S, Ahuja V. Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East. Inflamm Intest Dis. 2017;2:102-115. [PMID: 30018961 DOI: 10.1159/000465522] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 10.8] [Reference Citation Analysis]
71 Chua KH, Lian LH, Khor WC, Lee WS, Hilmi I, Goh KL, Kee BP. Association between genetic polymorphisms in interferon regulatory factor 5 (IRF5) gene and Malaysian patients with Crohn's disease. J Dig Dis 2015;16:205-16. [PMID: 25564941 DOI: 10.1111/1751-2980.12229] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
72 Yang S, Hong M, Oh H, Low H, Jung S, Ahn S, Kim Y, Baek J, Lee CH, Kim E, Kim KM, Ye BD, Kim K, Park SH, Lee H, Lee I, Shin HD, Han B, Mcgovern DP, Liu J, Song K. Identification of Loci at 1q21 and 16q23 That Affect Susceptibility to Inflammatory Bowel Disease in Koreans. Gastroenterology 2016;151:1096-1099.e4. [DOI: 10.1053/j.gastro.2016.08.025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
73 Zhai H, Liu A, Huang W, Liu X, Feng S, Wu J, Yao Y, Wang C, Li Q, Hao Q, Hu J, Zhang S. Increasing rate of inflammatory bowel disease: a 12-year retrospective study in NingXia, China. BMC Gastroenterol 2016;16:2. [PMID: 26754840 DOI: 10.1186/s12876-015-0405-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
74 Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659-665. [PMID: 19424654 DOI: 10.1007/s00535-009-0057-3] [Cited by in Crossref: 168] [Cited by in F6Publishing: 166] [Article Influence: 14.0] [Reference Citation Analysis]
75 Opstelten JL, Beelen RMJ, Leenders M, Hoek G, Brunekreef B, van Schaik FDM, Siersema PD, Eriksen KT, Raaschou-Nielsen O, Tjønneland A, Overvad K, Boutron-Ruault MC, Carbonnel F, de Hoogh K, Key TJ, Luben R, Chan SSM, Hart AR, Bueno-de-Mesquita HB, Oldenburg B. Exposure to Ambient Air Pollution and the Risk of Inflammatory Bowel Disease: A European Nested Case-Control Study. Dig Dis Sci 2016;61:2963-71. [PMID: 27461060 DOI: 10.1007/s10620-016-4249-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
76 Wang YF, Ou-yang Q, Xia B, Liu LN, Gu F, Zhou KF, Mei Q, Shi RH, Ran ZH, Wang XD, Hu PJ, Wu KC, Liu XG, Miao YL, Han Y, Wu XP, He GB, Zhong J, Liu GJ. Multicenter case-control study of the risk factors for ulcerative colitis in China. World J Gastroenterol 2013; 19(11): 1827-1833 [PMID: 23555172 DOI: 10.3748/wjg.v19.i11.1827] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
77 Li F, Liu X, Wang W, Zhang D. Consumption of vegetables and fruit and the risk of inflammatory bowel disease: a meta-analysis. European Journal of Gastroenterology & Hepatology 2015;27:623-30. [DOI: 10.1097/meg.0000000000000330] [Cited by in Crossref: 47] [Cited by in F6Publishing: 20] [Article Influence: 7.8] [Reference Citation Analysis]
78 Osei JA, Peña-Sánchez JN, Fowler SA, Muhajarine N, Kaplan GG, Lix LM. Population-Based Evidence From a Western Canadian Province of the Decreasing Incidence Rates and Trends of Inflammatory Bowel Disease Among Adults. J Can Assoc Gastroenterol 2021;4:186-93. [PMID: 34337319 DOI: 10.1093/jcag/gwaa028] [Reference Citation Analysis]
79 Park S, Chun J, Han KD, Soh H, Choi K, Kim JH, Lee J, Lee C, Im JP, Kim JS. Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study. World J Gastroenterol 2018; 24(42): 4798-4808 [PMID: 30479466 DOI: 10.3748/wjg.v24.i42.4798] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
80 Park SH, Yang SK, Hong SM, Park SK, Kim JW, Lee HJ, Yang DH, Jung KW, Kim KJ, Ye BD. Severe disease activity and cytomegalovirus colitis are predictive of a nonresponse to infliximab in patients with ulcerative colitis. Dig Dis Sci. 2013;58:3592-3599. [PMID: 23979435 DOI: 10.1007/s10620-013-2828-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
81 He W, Li Y, Liu M, Yu H, Chen Q, Chen Y, Ruan J, Ding Z, Zhang Y, Wang T. Citrus aurantium L. and Its Flavonoids Regulate TNBS-Induced Inflammatory Bowel Disease through Anti-Inflammation and Suppressing Isolated Jejunum Contraction. Int J Mol Sci 2018;19:E3057. [PMID: 30301267 DOI: 10.3390/ijms19103057] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
82 Ng SC, Woodrow S, Patel N, Subhani J, Harbord M. Role of genetic and environmental factors in British twins with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:725-736. [PMID: 21557397 DOI: 10.1002/ibd.21747] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
83 Racine A, Carbonnel F, Chan SS, Hart AR, Bueno-de-Mesquita HB, Oldenburg B, van Schaik FD, Tjønneland A, Olsen A, Dahm CC. Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study. Inflamm Bowel Dis. 2016;22:345-354. [PMID: 26717318 DOI: 10.1097/mib.0000000000000638] [Cited by in Crossref: 114] [Cited by in F6Publishing: 46] [Article Influence: 22.8] [Reference Citation Analysis]
84 Basaranoglu M, Ertan A, Mathew S, Najjar SM, Ala A, Demirbag AE, Senturk H. Rate and Predictors of Endoscopic Mucosal Healing in Biologic Naive Patients with Inflammatory Bowel Disease by Azathioprine Treatment: A Real World, 10 Years' Experience from a Single Centre in Turkey. J Gastrointest Dig Syst 2016;6:467. [PMID: 29057149 DOI: 10.4172/2161-069X.1000467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
85 Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621. [PMID: 20192811 DOI: 10.1146/annurev-immunol-030409-101225.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Raza A, Yousaf W, Giannella R, Shata MT. Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease. Expert Rev Clin Immunol. 2012;8:161-168. [PMID: 22288454 DOI: 10.1586/eci.11.96.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Shivakumar BM, Lakshmankumar B, Rao L, Bhat G, Suvarna D, Pai CG. Colorectal neoplasia in long-standing ulcerative colitis - a prospective study from a low-prevalence area. Colorectal Dis. 2013;15:e462-e468. [PMID: 23663532 DOI: 10.1111/codi.12276] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
88 Johari S, Gandhi T. A Randomized Single Blind Parallel Group Study Comparing Monoherbal Formulation Containing Holarrhena Antidysenterica Extract with Mesalamine in Chronic Ulcerative Colitis Patients. Anc Sci Life 2016;36:19-27. [PMID: 28182023 DOI: 10.4103/0257-7941.195409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
89 Chua KH, Lian LH, Kee BP, Thum CM, Lee WS, Hilmi I, Goh KL. Identification of DLG5 and SLC22A5 gene polymorphisms in Malaysian patients with Crohn's disease. J Dig Dis 2011;12:459-66. [PMID: 22118696 DOI: 10.1111/j.1751-2980.2011.00533.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
90 Safarpour AR, Mehrabi M, Keshtkar A, Edjtehadi F, Bagheri Lankarani K. Systematic review and meta-analysis of the incidence and prevalence and 30-year trend of inflammatory bowel diseases in Asia: a study protocol. BMJ Open 2019;9:e031854. [PMID: 31748306 DOI: 10.1136/bmjopen-2019-031854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
91 Ooi CJ, Fock KM, Makharia GK, Goh KL, Ling KL, Hilmi I, Lim WC, Kelvin T, Gibson PR, Gearry RB. The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol. 2010;25:453-468. [PMID: 20370724 DOI: 10.1111/j.1440-1746.2010.06241.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 8.8] [Reference Citation Analysis]
92 Reigada LC, Satpute A, Hoogendoorn CJ, Cohen BH, Lai J, Bao R, Dubinsky MC, Benkov KJ. Patient-reported Anxiety: A Possible Predictor of Pediatric Inflammatory Bowel Disease Health Care Use. Inflammatory Bowel Diseases 2016;22:2127-33. [DOI: 10.1097/mib.0000000000000864] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
93 Suzuki Y, Motoya S, Hanai H, Hibi T, Nakamura S, Lazar A, Robinson AM, Skup M, Mostafa NM, Huang B, Thakkar R, Watanabe M. Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis. J Gastroenterol 2017;52:1031-40. [PMID: 28321512 DOI: 10.1007/s00535-017-1325-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
94 Qiao YQ, Cai CW, Ran ZH. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered. J Dig Dis. 2016;17:800-810. [PMID: 27743467 DOI: 10.1111/1751-2980.12422] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
95 Raza A, Yousaf W, Giannella R, Shata MT. Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease. Expert Rev Clin Immunol. 2012;8:161-168. [PMID: 22288454 DOI: 10.1586/eci.11.96] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
96 Hwang SW, Kim JH, Im JP, Ye BD, Koo HS, Huh KC, Cheon JH, Kim YS, Kim YH, Han DS, Kim WH, Kim JS; Crohn's disease clinical network and cohort (CONNECT) study. Influence of age at diagnosis on the clinical characteristics of Crohn's disease in Korea: Results from the CONNECT study. J Gastroenterol Hepatol 2017;32:1716-22. [PMID: 28251684 DOI: 10.1111/jgh.13775] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
97 Burke KE, Boumitri C, Ananthakrishnan AN. Modifiable Environmental Factors in Inflammatory Bowel Disease. Curr Gastroenterol Rep. 2017;19:21. [PMID: 28397132 DOI: 10.1007/s11894-017-0562-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
98 Wang X, Hao GL, Wang BY, Gao CC, Wang YX, Li LS, Xu JD. Function and dysfunction of plasma cells in intestine. Cell Biosci 2019;9:26. [PMID: 30911371 DOI: 10.1186/s13578-019-0288-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
99 Ghoshal UC, Gwee K, Holtmann G, Li Y, Park SJ, Simadibrata M, Sugano K, Wu K, Quigley EMM, Cohen H. The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia-Pacific region - background and recommendations of a regional consensus meeting: Gut microbiome/probiotics in Asia-Pacific. Journal of Gastroenterology and Hepatology 2018;33:57-69. [DOI: 10.1111/jgh.13840] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
100 Zhiqin W, Palaniappan S, Raja Ali RA. Inflammatory Bowel Disease-related Colorectal Cancer in the Asia-Pacific Region: Past, Present, and Future. Intest Res 2014;12:194-204. [PMID: 25349593 DOI: 10.5217/ir.2014.12.3.194] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
101 Ye L, Cao Q, Cheng J. Review of inflammatory bowel disease in China. ScientificWorldJournal. 2013;2013:296470. [PMID: 24348149 DOI: 10.1155/2013/296470] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
102 Young Cho J, Yeon Kim H, Me Kim H, Na Song H, Hong E, Hwang J, Sook Chun H. Standardized ethanolic extract of the rhizome of Curcuma xanthorrhiza prevents murine ulcerative colitis by regulation of inflammation. Journal of Functional Foods 2017;30:282-9. [DOI: 10.1016/j.jff.2017.01.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Murakami Y, Nishiwaki Y, Oba MS, Asakura K, Ohfuji S, Fukushima W, Suzuki Y, Nakamura Y. Estimated prevalence of ulcerative colitis and Crohn's disease in Japan in 2014: an analysis of a nationwide survey. J Gastroenterol 2019;54:1070-7. [PMID: 31309327 DOI: 10.1007/s00535-019-01603-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
104 Bodiwala V, Marshall T, Das KM, Brant SR, Seril DN. Comparison of Disease Phenotypes and Clinical Characteristics Among South Asian and White Patients with Inflammatory Bowel Disease at a Tertiary Referral Center. Inflammatory Bowel Diseases 2020;26:1869-77. [DOI: 10.1093/ibd/izaa019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
105 Jussila A, Virta LJ, Kautiainen H, Rekiaro M, Nieminen U, Färkkilä MA. Increasing incidence of inflammatory bowel diseases between 2000 and 2007: a nationwide register study in Finland. Inflamm Bowel Dis. 2012;18:555-561. [PMID: 21425214 DOI: 10.1002/ibd.21695] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
106 Ahmed I, Roy BC, Khan SA, Septer S, Umar S. Microbiome, Metabolome and Inflammatory Bowel Disease. Microorganisms. 2016;4:20. [PMID: 27681914 DOI: 10.3390/microorganisms4020020] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 13.0] [Reference Citation Analysis]
107 Luo CX, Wen ZH, Zhen Y, Wang ZJ, Mu JX, Zhu M, Ouyang Q, Zhang H. Chinese research into severe ulcerative colitis has increased in quantity and complexity. World J Clin Cases 2018; 6(3): 35-43 [PMID: 29564356 DOI: 10.12998/wjcc.v6.i3.35] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
108 Song KH, Kim ES, Lee YJ, Jang BI, Kim KO, Kwak SG, Lee HS; Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD). Characteristics and management of patients with inflammatory bowel disease between a secondary and tertiary hospitals: a propensity score analysis. Intest Res 2018;16:216-22. [PMID: 29743834 DOI: 10.5217/ir.2018.16.2.216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
109 Kumari R, Ahuja V, Paul J. Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India. World J Gastroenterol 2013; 19(22): 3404-3414 [PMID: 23801832 DOI: 10.3748/wjg.v19.i22.3404] [Cited by in CrossRef: 97] [Cited by in F6Publishing: 83] [Article Influence: 12.1] [Reference Citation Analysis]
110 Govani SM, Wiitala WL, Stidham RW, Saini SD, Hou JK, Feagins LA, Sussman JB, Higgins PD, Waljee AK. Age Disparities in the Use of Steroid-sparing Therapy for Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:1923-8. [PMID: 27416039 DOI: 10.1097/MIB.0000000000000817] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
111 Miao YL, Xiao YL, Du Y, Duan LP. Gene expression profiles in peripheral blood mononuclear cells of ulcerative colitis patients. World J Gastroenterol 2013; 19(21): 3339-3346 [PMID: 23745037 DOI: 10.3748/wjg.v19.i21.3339] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
112 Ng SC. Epidemiology of inflammatory bowel disease: focus on Asia. Best Pract Res Clin Gastroenterol. 2014;28:363-372. [PMID: 24913377 DOI: 10.1016/j.bpg.2014.04.003] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 12.1] [Reference Citation Analysis]
113 Desai D, Shah S, Deshmukh A, Abraham P, Joshi A, Gupta T, Deshpande R, Khandagale V, George S. Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer. World J Gastroenterol 2015; 21(12): 3644-3649 [PMID: 25834332 DOI: 10.3748/wjg.v21.i12.3644] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
114 Van Limbergen J, Radford-Smith G, Satsangi J. Advances in IBD genetics. Nat Rev Gastroenterol Hepatol. 2014;11:372-385. [PMID: 24614343 DOI: 10.1038/nrgastro.2014.27] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 13.4] [Reference Citation Analysis]
115 Shanahan F, Bernstein CN. The evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol. 2009;25:301-305. [PMID: 19349861 DOI: 10.1097/mog.0b013e32832b12ef] [Cited by in Crossref: 73] [Cited by in F6Publishing: 34] [Article Influence: 6.1] [Reference Citation Analysis]
116 Talley NJ, Abreu MT, Achkar JP, Bernstein CN, Dubinsky MC, Hanauer SB, Kane SV, Sandborn WJ, Ullman TA, Moayyedi P. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol. 2011;106 Suppl 1:S2-S25; quiz S26. [PMID: 21472012 DOI: 10.1038/ajg.2011.58] [Cited by in Crossref: 177] [Cited by in F6Publishing: 165] [Article Influence: 17.7] [Reference Citation Analysis]
117 Lee YW, Chung WC, Sung HJ, Kang YG, Hong SL, Cho KW, Kang D, Lee IH, Jeon EJ. Current status and clinical impact of pediatric endoscopy in Korea. Korean J Gastroenterol 2014;64:333-9. [PMID: 25530584 DOI: 10.4166/kjg.2014.64.6.333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
118 Kronsteiner B, Bassaganya-Riera J, Philipson C, Viladomiu M, Carbo A, Abedi V, Hontecillas R. Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis. Gut Microbes 2016;7:3-21. [PMID: 26939848 DOI: 10.1080/19490976.2015.1116673] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
119 Kumagai J, Taida T, Ogasawara S, Nakagawa T, Iino Y, Shingyoji A, Ishikawa K, Akizue N, Yamato M, Takahashi K, Ohta Y, Hamanaka S, Okimoto K, Nakamura M, Ohyama H, Saito K, Kusakabe Y, Maruoka D, Yasui S, Matsumura T, Sugiyama H, Sakai Y, Mikata R, Arai M, Katsuno T, Tsuyuguchi T, Kato N. Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients. PLoS One. 2018;13:e0209352. [PMID: 30571774 DOI: 10.1371/journal.pone.0209352] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
120 Shah SC, Khalili H, Gower-rousseau C, Olen O, Benchimol EI, Lynge E, Nielsen KR, Brassard P, Vutcovici M, Bitton A, Bernstein CN, Leddin D, Tamim H, Stefansson T, Loftus EV, Moum B, Tang W, Ng SC, Gearry R, Sincic B, Bell S, Sands BE, Lakatos PL, Végh Z, Ott C, Kaplan GG, Burisch J, Colombel J. Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries. Gastroenterology 2018;155:1079-1089.e3. [DOI: 10.1053/j.gastro.2018.06.043] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 24.3] [Reference Citation Analysis]
121 Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016;14:111-119. [PMID: 27175111 DOI: 10.5217/ir.2016.14.2.111] [Cited by in Crossref: 159] [Cited by in F6Publishing: 148] [Article Influence: 31.8] [Reference Citation Analysis]
122 Sun F, Liang W, Tang K, Hong M, Qian J. Profiling the lncRNA-miRNA-mRNA ceRNA network to reveal potential crosstalk between inflammatory bowel disease and colorectal cancer. PeerJ 2019;7:e7451. [PMID: 31523496 DOI: 10.7717/peerj.7451] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
123 Thia KT, Li M, Ling KL, Kong SC, Ooi CJ. Azathioprine is effective in corticosteroid-dependent Asian inflammatory bowel disease patients. Inflamm Bowel Dis. 2011;17:809-815. [PMID: 20645318 DOI: 10.1002/ibd.21382] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
124 Singh UP, Singh NP, Singh B, Mishra MK, Nagarkatti M, Nagarkatti PS, Singh SR. Stem cells as potential therapeutic targets for inflammatory bowel disease. Front Biosci (Schol Ed). 2010;2:993-1008. [PMID: 20515838 DOI: 10.2741/s115] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
125 Lee JW, Im JP, Cheon JH, Kim YS, Kim JS, Han DS. Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future. Intest Res. 2015;13:213-218. [PMID: 26130995 DOI: 10.5217/ir.2015.13.3.213] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
126 Klein A, Mazor Y, Karban A, Ben-Itzhak O, Chowers Y, Sabo E. Early histological findings may predict the clinical phenotype in Crohn's colitis. United European Gastroenterol J. 2017;5:694-701. [PMID: 28815033 DOI: 10.1177/2050640616676435] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
127 Gu P, Feagins LA. Dining With Inflammatory Bowel Disease: A Review of the Literature on Diet in the Pathogenesis and Management of IBD. Inflamm Bowel Dis 2020;26:181-91. [PMID: 31670372 DOI: 10.1093/ibd/izz268] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
128 Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology. 2013;145:970-977. [PMID: 23912083 DOI: 10.1053/j.gastro.2013.07.050] [Cited by in Crossref: 290] [Cited by in F6Publishing: 234] [Article Influence: 36.3] [Reference Citation Analysis]
129 Kim JW, Lee CK, Lee JK, Jeong SJ, Oh SJ, Moon JR, Kim HS, Kim HJ. Long-term evolution of direct healthcare costs for inflammatory bowel diseases: a population-based study (2006-2015). Scand J Gastroenterol 2019;54:419-26. [PMID: 30905222 DOI: 10.1080/00365521.2019.1591498] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
130 Cope G. Overview of dietary choices for ulcerative colitis and Crohn's disease. Gastrointestinal Nursing 2015;13:35-41. [DOI: 10.12968/gasn.2015.13.1.35] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
131 Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785-1794. [PMID: 21530745 DOI: 10.1053/j.gastro.2011.01.055] [Cited by in Crossref: 1157] [Cited by in F6Publishing: 1047] [Article Influence: 115.7] [Reference Citation Analysis]
132 Pan WJ, Köck K, Rees WA, Sullivan BA, Evangelista CM, Yen M, Andrews JM, Radford-Smith GL, Prince PJ, Reynhardt KO. Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases. Br J Clin Pharmacol. 2014;78:1315-1333. [PMID: 24803302 DOI: 10.1111/bcp.12418] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
133 Aljebreen AM, Alharbi OR, Azzam NA, Almalki AS, Alswat KA, Almadi MA. Clinical epidemiology and phenotypic characteristics of Crohn's disease in the central region of Saudi Arabia. Saudi J Gastroenterol 2014;20:162-9. [PMID: 24976279 DOI: 10.4103/1319-3767.132993] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
134 Aziz DA, Moin M, Majeed A, Sadiq K, Biloo AG. Paediatric Inflammatory Bowel Disease: Clinical Presentation and Disease Location. Pak J Med Sci 2017;33:793-7. [PMID: 29067041 DOI: 10.12669/pjms.334.12926] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
135 Cha JM, Park DI, Park SH, Shin JE, Kim WS, Yang SK. Physicians Should Provide Shared Decision-Making for Anti-TNF Therapy to Inflammatory Bowel Disease Patients. J Korean Med Sci 2017;32:85-94. [PMID: 27914136 DOI: 10.3346/jkms.2017.32.1.85] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
136 Ye BD, Yang SK, Boo SJ, Cho YK, Yang DH, Yoon SM, Kim KJ, Byeon JS, Myung SJ, Yu CS, Yun SC, Kim JH. Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea. Inflamm Bowel Dis. 2011;17:1901-1906. [PMID: 21830268 DOI: 10.1002/ibd.21569] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
137 Ujihara M, Ando T, Ishiguro K, Maeda O, Watanabe O, Hirayama Y, Morise K, Maeda K, Matsushita M, Miyahara R, Ohmiya N, Nishio Y, Yamaguchi T, Haruta J, Ina K, Goto H. Importance of appropriate pharmaceutical management in pregnant women with ulcerative colitis. BMC Res Notes 2013;6:210. [PMID: 23706098 DOI: 10.1186/1756-0500-6-210] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
138 Basson A, Swart R, Jordaan E, Mazinu M, Watermeyer G. The association between race and Crohn's disease phenotype in the Western Cape population of South Africa, defined by the Montreal Classification System. PLoS One 2014;9:e104859. [PMID: 25118187 DOI: 10.1371/journal.pone.0104859] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
139 Song EM, Lee HS, Park SH, Kim GU, Seo M, Hwang SW, Yang DH, Kim KJ, Byeon JS, Myung SJ, Yang SK, Ye BD. Clinical characteristics and long-term prognosis of elderly onset ulcerative colitis. J Gastroenterol Hepatol 2018;33:172-9. [PMID: 28543366 DOI: 10.1111/jgh.13826] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
140 Leung CM, Tang W, Kyaw M, Niamul G, Aniwan S, Limsrivilai J, Wang Y, Ouyang Q, Simadibrata M, Abdullah M, Ong DE, Yu HH, Zhang J, Ching J, Wu JCY, Chan FKL, Sung JJY, Ng SC. Endoscopic and Histological Mucosal Healing in Ulcerative Colitis in the First Year of Diagnosis: Results from a Population-based Inception Cohort from Six Countries in Asia. Journal of Crohn's and Colitis 2017;11:1440-8. [DOI: 10.1093/ecco-jcc/jjx103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
141 Ng SC, Tsoi KK, Kamm MA, Xia B, Wu J, Chan FK, Sung JJ. Genetics of inflammatory bowel disease in Asia: Systematic review and meta-analysis: . Inflammatory Bowel Diseases 2012;18:1164-76. [DOI: 10.1002/ibd.21845] [Cited by in Crossref: 108] [Cited by in F6Publishing: 114] [Article Influence: 12.0] [Reference Citation Analysis]
142 Papamichael K, Konstantopoulos P, Mantzaris GJ. Helicobacter pylori infection and inflammatory bowel disease: Is there a link? World J Gastroenterol 2014; 20(21): 6374-6385 [PMID: 24914359 DOI: 10.3748/wjg.v20.i21.6374] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 48] [Article Influence: 6.6] [Reference Citation Analysis]
143 Chan SS, Luben R, van Schaik F, Oldenburg B, Bueno-de-Mesquita HB, Hallmans G, Karling P, Lindgren S, Grip O, Key T. Carbohydrate intake in the etiology of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2014;20:2013-2021. [PMID: 25265262 DOI: 10.1097/mib.0000000000000168] [Cited by in Crossref: 50] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
144 Epstein J, Docena G, MacDonald TT, Sanderson IR. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease. Br J Nutr. 2010;103:824-832. [PMID: 19878610 DOI: 10.1017/s0007114509992510] [Cited by in Crossref: 75] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
145 Chun J, Im JP, Kim JW, Lee KL, Choi CH, Kim H, Cheon JH, Ye BD, Kim YH, Kim YS, Jeen YT, Han DS, Kim WH, Kim JS. Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study. Gut Liver 2018;12:544-54. [PMID: 30037171 DOI: 10.5009/gnl18157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
146 Qu C, Yuan ZW, Yu XT, Huang YF, Yang GH, Chen JN, Lai XP, Su ZR, Zeng HF, Xie Y, Zhang XJ. Patchouli alcohol ameliorates dextran sodium sulfate-induced experimental colitis and suppresses tryptophan catabolism. Pharmacol Res. 2017;121:70-82. [PMID: 28456683 DOI: 10.1016/j.phrs.2017.04.017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
147 Park SH, Yang SK, Lim YS, Shim JH, Yang DH, Jung KW, Kim KJ, Ye BD, Byeon JS, Myung SJ, Kim JH. Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases. Inflamm Bowel Dis. 2012;18:2004-2010. [PMID: 22337144 DOI: 10.1002/ibd.22905] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
148 Tajiri H, Motoya S, Kinjo F, Maemoto A, Matsumoto T, Sato N, Yamada H, Nagano M, Susuta Y, Ozaki K, Kondo K, Hibi T. Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan. PLoS One 2018;13:e0201956. [PMID: 30114224 DOI: 10.1371/journal.pone.0201956] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
149 Al-Jarallah K, Shehab D, Al-Azmi W, Al-Fadli A. Rheumatic complications of inflammatory bowel disease among Arabs: a hospital-based study in Kuwait. Int J Rheum Dis. 2013;16:134-138. [PMID: 23773636 DOI: 10.1111/j.1756-185x.2012.01811.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
150 Tsai MS, Lin CL, Chen HP, Lee PH, Sung FC, Kao CH. Long-term risk of acute coronary syndrome in patients with inflammatory bowel disease: a 13-year nationwide cohort study in an Asian population. Inflamm Bowel Dis. 2014;20:502-507. [PMID: 24412991 DOI: 10.1097/01.mib.0000441200.10454.4f] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 2.9] [Reference Citation Analysis]
151 Lui RNS, Ng SC. The Same Intestinal Inflammatory Disease despite Different Genetic Risk Factors in the East and West? Inflamm Intest Dis 2016;1:78-84. [PMID: 29922661 DOI: 10.1159/000446625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
152 Ananthakrishnan AN. Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci. 2015;60:290-298. [PMID: 25204669 DOI: 10.1007/s10620-014-3350-9] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 11.9] [Reference Citation Analysis]
153 Yang SK. How Does the Epidemiology of Inflammatory Bowel Disease Differ between East and West? A Korean Perspective. Inflamm Intest Dis. 2017;2:95-101. [PMID: 30018960 DOI: 10.1159/000454712] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
154 崔海梦, 罗庆锋, 许乐. 幽门螺旋杆菌与胃外疾病相关性研究进展. 世界华人消化杂志 2015; 23(14): 2221-2227 [DOI: 10.11569/wcjd.v23.i14.2221] [Reference Citation Analysis]
155 Dalal SR, Chang EB. The microbial basis of inflammatory bowel diseases. J Clin Invest. 2014;124:4190-4196. [PMID: 25083986 DOI: 10.1172/jci72330] [Cited by in Crossref: 123] [Cited by in F6Publishing: 62] [Article Influence: 17.6] [Reference Citation Analysis]
156 Siddique I, Alazmi W, Al-Ali J, Al-Fadli A, Alateeqi N, Memon A, Hasan F. Clinical epidemiology of Crohn’s disease in Arabs based on the Montreal Classification. Inflamm Bowel Dis. 2012;18:1689-1697. [PMID: 21987450 DOI: 10.1002/ibd.21890] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
157 Park SH, Kim YJ, Rhee KH, Kim YH, Hong SN, Kim KH, Seo SI, Cha JM, Park SY, Jeong SK, Lee JH, Park H, Kim JS, Im JP, Yoon H, Kim SH, Jang J, Kim JH, Suh SO, Kim YK, Ye BD, Yang SK; Songpa-Kangdong Inflammatory Bowel Disease [SK-IBD] Study Group. A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986-2015. J Crohns Colitis. 2019;13:1410-1417. [PMID: 30989166 DOI: 10.1093/ecco-jcc/jjz081] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 39.0] [Reference Citation Analysis]
158 Ng SC, Leung WK, Shi HY, Li MK, Leung CM, Ng CK, Lo FH, Hui YT, Tsang SW, Chan YK. Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong. Inflamm Bowel Dis. 2016;22:1954-1960. [PMID: 27416041 DOI: 10.1097/mib.0000000000000846] [Cited by in Crossref: 61] [Cited by in F6Publishing: 26] [Article Influence: 20.3] [Reference Citation Analysis]
159 Choi J, Chung K, Jin B, Cheon S, Nugroho A, Roh S, An H. Anti-inflammatory effects of an ethanol extract of Aster glehni via inhibition of NF-κB activation in mice with DSS-induced colitis. Food Funct 2017;8:2611-20. [DOI: 10.1039/c7fo00369b] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
160 Goel A, Dutta AK, Pulimood AB, Eapen A, Chacko A. Clinical profile and predictors of disease behavior and surgery in Indian patients with Crohn's disease. Indian J Gastroenterol. 2013;32:184-189. [PMID: 23417764 DOI: 10.1007/s12664-012-0293-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
161 Radi ZA, Heuvelman DM, Masferrer JL, Benson EL. Pharmacologic evaluation of sulfasalazine, FTY720, and anti-IL-12/23p40 in a TNBS-induced Crohn's disease model. Dig Dis Sci 2011;56:2283-91. [PMID: 21374065 DOI: 10.1007/s10620-011-1628-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
162 Ananthakrishnan AN. Personalizing therapy for inflammatory bowel diseases. Expert Rev Gastroenterol Hepatol 2013;7:549-58. [PMID: 23985004 DOI: 10.1586/17474124.2013.824693] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
163 Shin DH, Sinn DH, Kim YH, Kim JY, Chang DK, Kim EJ, Ryu HY, Song HU, Kim IY, Kim do H. Increasing incidence of inflammatory bowel disease among young men in Korea between 2003 and 2008. Dig Dis Sci. 2011;56:1154-1159. [PMID: 20844953 DOI: 10.1007/s10620-010-1403-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
164 De Cruz P, Prideaux L, Wagner J, Ng SC, McSweeney C, Kirkwood C, Morrison M, Kamm MA. Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:372-390. [PMID: 21604329 DOI: 10.1002/ibd.21751] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 7.0] [Reference Citation Analysis]
165 Stepaniuk P, Bernstein CN, Nugent Z, Singh H. Characterization of inflammatory bowel disease in elderly hospitalized patients in a large central Canadian Health region. Can J Gastroenterol Hepatol 2015;29:274-8. [PMID: 25874650 DOI: 10.1155/2015/724359] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
166 Chatzikonstantinou M, Konstantopoulos P, Stergiopoulos S, Kontzoglou K, Verikokos C, Perrea D, Dimitroulis D. Calprotectin as a diagnostic tool for inflammatory bowel diseases. Biomed Rep 2016;5:403-7. [PMID: 27699005 DOI: 10.3892/br.2016.751] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
167 Lee EJ, Kim TO, Song GA, Lee JH, Kim HW, Jee SR, Park SJ, Kim HJ, Park JH. Clinical features of Crohn's disease in Korean patients residing in Busan and Gyeongnam. Intest Res 2016;14:30-6. [PMID: 26884732 DOI: 10.5217/ir.2016.14.1.30] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
168 Oikonomopoulos A, Polytarchou C, Joshi S, Hommes DW, Iliopoulos D. Identification of Circulating MicroRNA Signatures in Crohn's Disease Using the Nanostring nCounter Technology. Inflamm Bowel Dis 2016;22:2063-9. [PMID: 27542126 DOI: 10.1097/MIB.0000000000000883] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
169 Kim YG, Kim KJ, Min YK. Comparison of small bowel findings using capsule endoscopy between Crohn's disease and intestinal tuberculosis in Korea. Yeungnam Univ J Med 2020;37:98-105. [PMID: 31847061 DOI: 10.12701/yujm.2019.00374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
170 Owyang SY, Luther J, Kao JY. Helicobacter pylori: beneficial for most? Expert Rev Gastroenterol Hepatol 2011;5:649-51. [PMID: 22017690 DOI: 10.1586/egh.11.69] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
171 Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, Li MF, Ng KK, Kamm MA, Studd C, Bell S, Leong R, de Silva HJ, Kasturiratne A, Mufeena MNF, Ling KL, Ooi CJ, Tan PS, Ong D, Goh KL, Hilmi I, Pisespongsa P, Manatsathit S, Rerknimitr R, Aniwan S, Wang YF, Ouyang Q, Zeng Z, Zhu Z, Chen MH, Hu PJ, Wu K, Wang X, Simadibrata M, Abdullah M, Wu JC, Sung JJY, Chan FKL; Asia-Pacific Crohn's and Colitis Epidemiologic Study (ACCESS) Study Group. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology. 2013;145:158-165. [PMID: 23583432 DOI: 10.1053/j.gastro.2013.04.007] [Cited by in Crossref: 413] [Cited by in F6Publishing: 388] [Article Influence: 51.6] [Reference Citation Analysis]
172 Jin X, Chen YP, Chen SH, Xiang Z. Association between Helicobacter Pylori infection and ulcerative colitis--a case control study from China. Int J Med Sci. 2013;10:1479-1484. [PMID: 24046521 DOI: 10.7150/ijms.6934] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
173 Kim J, Lee H, Park SH, Yang S, Ye BD, Yang D, Kim K, Byeon J, Yoon YS, Yu CS, Kim J. Pathologic features of colorectal carcinomas associated with Crohn’s disease in Korean population. Pathology - Research and Practice 2017;213:250-5. [DOI: 10.1016/j.prp.2016.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
174 Kalubowila U, Liyanaarachchi T, Galketiya KB, Rathnayaka P, Piyasena INAP, Tennakoon S, Perera KMP, Pathirana SDMU, Wettewa DB, Ratnayake WRANMP, Raayiz RM, Dissanayaka DMIU. Epidemiology and clinical course of inflammatory bowel disease in the Central Province of Sri Lanka: A hospital-based study. JGH Open. 2018;2:129-133. [PMID: 30483577 DOI: 10.1002/jgh3.12058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
175 Kim HJ, Hann HJ, Hong SN, Kim KH, Ahn IM, Song JY, Lee SH, Ahn HS. Incidence and natural course of inflammatory bowel disease in Korea, 2006-2012: a nationwide population-based study. Inflamm Bowel Dis. 2015;21:623-630. [PMID: 25647154 DOI: 10.1097/mib.0000000000000313] [Cited by in Crossref: 98] [Cited by in F6Publishing: 51] [Article Influence: 16.3] [Reference Citation Analysis]
176 Ghanadi K, Valizadeh J, Hasanvand A. Epidemiological and clinical aspects of ulcerative colitis in west of Iran: a cross sectional study. Springerplus 2016;5:1588. [PMID: 27652161 DOI: 10.1186/s40064-016-3248-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
177 Ooi CJ, Makharia GK, Hilmi I, Gibson PR, Fock KM, Ahuja V, Ling KL, Lim WC, Thia KT, Wei SC, Leung WK, Koh PK, Gearry RB, Goh KL, Ouyang Q, Sollano J, Manatsathit S, de Silva HJ, Rerknimitr R, Pisespongsa P, Abu Hassan MR, Sung J, Hibi T, Boey CC, Moran N, Leong RW; Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease. Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus--Part 1). J Gastroenterol Hepatol. 2016;31:45-55. [PMID: 25819140 DOI: 10.1111/jgh.12956] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 12.2] [Reference Citation Analysis]
178 Burisch J, Jess T, Martinato M, Lakatos PL; ECCO -EpiCom. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013;7:322-337. [PMID: 23395397 DOI: 10.1016/j.crohns.2013.01.010] [Cited by in Crossref: 541] [Cited by in F6Publishing: 487] [Article Influence: 67.6] [Reference Citation Analysis]
179 Jang JY, Song SM, Kim KM, Oh SH, Lee YJ, Rhee KW. Lack of common NOD2 mutations in Korean pediatric patients with inflammatory bowel disease: NOD2 mutations in Korean children. Pediatrics International 2010;52:888-9. [DOI: 10.1111/j.1442-200x.2010.03269.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
180 Penagini F, Dilillo D, Borsani B, Cococcioni L, Galli E, Bedogni G, Zuin G, Zuccotti GV. Nutrition in Pediatric Inflammatory Bowel Disease: From Etiology to Treatment. A Systematic Review. Nutrients. 2016;8. [PMID: 27258308 DOI: 10.3390/nu8060334] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
181 Ahluwalia JP. Immunotherapy in Inflammatory Bowel Disease. Medical Clinics of North America 2012;96:525-44. [DOI: 10.1016/j.mcna.2012.04.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
182 Ewald PW, Swain Ewald HA. An evolutionary perspective on the causes and treatment of inflammatory bowel disease: . Current Opinion in Gastroenterology 2013;29:350-6. [DOI: 10.1097/mog.0b013e328361f80f] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
183 McCombie AM, Mulder RT, Gearry RB. Psychotherapy for inflammatory bowel disease: a review and update. J Crohns Colitis. 2013;7:935-949. [PMID: 23466412 DOI: 10.1016/j.crohns.2013.02.004] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 8.5] [Reference Citation Analysis]
184 Palacio FGM, de Souza LMP, Moreira JPL, Luiz RR, de Souza HSP, Zaltman C. Hospitalization and surgery rates in patients with inflammatory bowel disease in Brazil: a time-trend analysis. BMC Gastroenterol 2021;21:192. [PMID: 33906627 DOI: 10.1186/s12876-021-01781-x] [Reference Citation Analysis]
185 Ray G. Inflammatory bowel disease in India--changing paradigms. Int J Colorectal Dis. 2011;26:635-644. [PMID: 21063715 DOI: 10.1007/s00384-010-1084-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
186 Park JJ, Yang SK, Ye BD, Kim JW, Park DI, Yoon H, Im JP, Lee KM, Yoon SN, Lee H; IBD Study Group of the Korean Association for the Study of Intestinal Diseases. Second Korean guidelines for the management of Crohn's disease. Intest Res 2017;15:38-67. [PMID: 28239314 DOI: 10.5217/ir.2017.15.1.38] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
187 Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol 2012;27:1266-80. [PMID: 22497584 DOI: 10.1111/j.1440-1746.2012.07150.x] [Cited by in Crossref: 195] [Cited by in F6Publishing: 196] [Article Influence: 21.7] [Reference Citation Analysis]
188 Sepehri S, Khafipour E, Bernstein CN, Coombes BK, Pilar AV, Karmali M, Ziebell K, Krause DO. Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:1451-1463. [PMID: 21674703 DOI: 10.1002/ibd.21509] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
189 Payne SC, Furness JB, Stebbing MJ. Bioelectric neuromodulation for gastrointestinal disorders: effectiveness and mechanisms. Nat Rev Gastroenterol Hepatol 2019;16:89-105. [PMID: 30390018 DOI: 10.1038/s41575-018-0078-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 21.0] [Reference Citation Analysis]
190 Abdullah M, Syam AF, Simadibrata M, Gunawan J, Makmun D, Rani AA. New insights on the pathomechanisms of inflammatory bowel disease: New insights on IBD pathomechanisms. Journal of Digestive Diseases 2013;14:455-62. [DOI: 10.1111/1751-2980.12081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
191 Azzman N. Crohn's Disease: Potential Drugs for Modulation of Autophagy. Medicina (Kaunas) 2019;55:E224. [PMID: 31146413 DOI: 10.3390/medicina55060224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis. 2010;16:1077-1084. [PMID: 19760778 DOI: 10.1002/ibd] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
193 Wu S, Chen Z. Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo. Exp Ther Med 2019;18:2877-84. [PMID: 31572532 DOI: 10.3892/etm.2019.7907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
194 Choi YJ, Choi EK, Han KD, Park J, Moon I, Lee E, Choe WS, Lee SR, Cha MJ, Lim WH, Oh S. Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study. World J Gastroenterol 2019; 25(22): 2788-2798 [PMID: 31236001 DOI: 10.3748/wjg.v25.i22.2788] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
195 Sodagari HR, Farzaei MH, Bahramsoltani R, Abdolghaffari AH, Mahmoudi M, Rezaei N. Dietary anthocyanins as a complementary medicinal approach for management of inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2015;9:807-20. [PMID: 25586636 DOI: 10.1586/17474124.2015.1002086] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
196 Selvaratnam S, Gullino S, Shim L, Lee E, Lee A, Paramsothy S, Leong RW. Epidemiology of inflammatory bowel disease in South America: A systematic review. World J Gastroenterol 2019; 25(47): 6866-6875 [PMID: 31885427 DOI: 10.3748/wjg.v25.i47.6866] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
197 Matsuoka K, Uemura Y, Kanai T, Kunisaki R, Suzuki Y, Yokoyama K, Yoshimura N, Hibi T. Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis. Dig Dis Sci. 2018;63:1910-1919. [PMID: 29450747 DOI: 10.1007/s10620-018-4946-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 9.7] [Reference Citation Analysis]
198 Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn's disease. Dis Mon. 2018;64:20-57. [PMID: 28826742 DOI: 10.1016/j.disamonth.2017.07.001] [Cited by in Crossref: 108] [Cited by in F6Publishing: 88] [Article Influence: 27.0] [Reference Citation Analysis]
199 Murdoch TB, Bernstein CN, El-Gabalawy H, Stempak JM, Sargent M, Elias B, Xu W, Pathan S, Silverberg MS. Prevalence of genetic variants associated with inflammatory bowel disease in a healthy First Nations cohort. CMAJ 2012;184:E435-41. [PMID: 22496383 DOI: 10.1503/cmaj.110613] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
200 Zhang YZ, Li YY. Inflammatory bowel disease: Pathogenesis. World J Gastroenterol 2014; 20(1): 91-99 [PMID: 24415861 DOI: 10.3748/wjg.v20.i1.91] [Cited by in CrossRef: 441] [Cited by in F6Publishing: 382] [Article Influence: 63.0] [Reference Citation Analysis]
201 Cui G, Yuan A. A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease. Front Med (Lausanne). 2018;5:183. [PMID: 29971235 DOI: 10.3389/fmed.2018.00183] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
202 Wang L, Yang Y, Cheng W, Wang W, Lin S, Shieh C. Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan. American Journal of Gastroenterology 2016;111:1313-9. [DOI: 10.1038/ajg.2016.239] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
203 Chen HL, Li LR. Glucocorticoid receptor gene polymorphisms and glucocorticoid resistance in inflammatory bowel disease: a meta-analysis. Dig Dis Sci. 2012;57:3065-3075. [PMID: 22752665 DOI: 10.1007/s10620-012-2293-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
204 Jonkers D, Penders J, Masclee A, Pierik M. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs. 2012;72:803-823. [PMID: 22512365 DOI: 10.2165/11632710-000000000-00000] [Cited by in Crossref: 145] [Cited by in F6Publishing: 125] [Article Influence: 16.1] [Reference Citation Analysis]
205 Roberts SE, Wotton CJ, Williams JG, Griffith M, Goldacre MJ. Perinatal and early life risk factors for inflammatory bowel disease. World J Gastroenterol 2011; 17(6): 743-749 [PMID: 21390144 DOI: 10.3748/wjg.v17.i6.743] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
206 Wei SC, Ni YH, Yang HI, Su YN, Chang MC, Chang YT, Shieh MJ, Wang CY, Wong JM. A hospital-based study of clinical and genetic features of Crohn's disease. J Formos Med Assoc 2011;110:600-6. [PMID: 21930071 DOI: 10.1016/j.jfma.2011.07.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
207 Farkas K, Chan H, Rutka M, Szepes Z, Nagy F, Tiszlavicz L, Nyári T, Tang W, Wong G, Tang R, Lo A, Cheung C, Wong S, Lui R, Molnár T, Ng SC. Gastroduodenal Involvement in Asymptomatic Crohn’s Disease Patients in Two Areas of Emerging Disease: Asia and Eastern Europe. ECCOJC 2016;10:1401-6. [DOI: 10.1093/ecco-jcc/jjw113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
208 Makharia GK, Ramakrishna BS, Abraham P, Choudhuri G, Misra SP, Ahuja V, Bhatia SJ, Bhasin DK, Dadhich S, Dhali GK, Desai DC, Ghoshal UC, Goswami BD, Issar SK, Jain AK, Jayanthi V, Loganathan G, Pai CG, Puri AS, Rana SS, Ray G, Singh SP, Sood A; Indian Society of Gastroenterology Task Force on Inflammatory Bowel Disease. Survey of inflammatory bowel diseases in India. Indian J Gastroenterol. 2012;31:299-306. [PMID: 23073755 DOI: 10.1007/s12664-012-0258-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
209 Shadnoush M, Hosseini RS, Khalilnezhad A, Navai L, Goudarzi H, Vaezjalali M. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. Korean J Gastroenterol. 2015;65:215-221. [PMID: 25896155 DOI: 10.4166/kjg.2015.65.4.215] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 7.8] [Reference Citation Analysis]
210 Lee HS, Choe J, Lee HJ, Hwang SW, Park SH, Yang DH, Kim KJ, Ye BD, Byeon JS, Myung SJ. Change in the diagnosis of inflammatory bowel disease: a hospital-based cohort study from Korea. Intest Res. 2016;14:258-263. [PMID: 27433148 DOI: 10.5217/ir.2016.14.3.258] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
211 Li Y, Tian Y, Zhu W, Gong J, Gu L, Zhang W, Guo Z, Li N, Li J. Cesarean delivery and risk of inflammatory bowel disease: a systematic review and meta-analysis. Scandinavian Journal of Gastroenterology 2014;49:834-44. [DOI: 10.3109/00365521.2014.910834] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
212 Jing Y, Li A, Liu Z, Yang P, Wei J, Chen X, Zhao T, Bai Y, Zha L, Zhang C. Absorption of Codonopsis pilosula Saponins by Coexisting Polysaccharides Alleviates Gut Microbial Dysbiosis with Dextran Sulfate Sodium-Induced Colitis in Model Mice. Biomed Res Int 2018;2018:1781036. [PMID: 30211217 DOI: 10.1155/2018/1781036] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
213 Feng BS, Chen X, Li P, Zheng PY, Chong J, Cho DB, He SH, Tang SG, Yang PC. Expression of integrin alphavbeta6 in the intestinal epithelial cells of patients with inflammatory bowel disease. N Am J Med Sci 2009;1:200-4. [PMID: 22666696 DOI: 10.4297/najms.2009.4200] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
214 Chua KH, Ng JG, Ng CC, Hilmi I, Goh KL, Kee BP. Association of NOD1, CXCL16, STAT6 and TLR4 gene polymorphisms with Malaysian patients with Crohn's disease. PeerJ. 2016;4:e1843. [PMID: 27069792 DOI: 10.7717/peerj.1843] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
215 Lv C, Yang X, Zhang Y, Zhao X, Chen Z, Long J, Zhang Y, Zhong C, Zhi J, Yao G, Jiang B, Zhi F. Confirmation of three inflammatory bowel disease susceptibility loci in a Chinese cohort. Int J Colorectal Dis 2012;27:1465-72. [DOI: 10.1007/s00384-012-1450-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
216 Ma JY, Tong JL, Ran ZH. Intestinal tuberculosis and Crohn's disease: challenging differential diagnosis. J Dig Dis 2016;17:155-61. [PMID: 26854750 DOI: 10.1111/1751-2980.12324] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
217 Wang PQ, Hu J, Al Kazzi ES, Akhuemonkhan E, Zhi M, Gao X, de Paula Pessoa RH, Ghazaleh S, Cornelius T, Sabunwala SA, Ghadermarzi S, Tripathi K, Lazarev M, Hu PJ, Hutfless S. Family history and disease outcomes in patients with Crohn’s disease: A comparison between China and the United States. World J Gastrointest Pharmacol Ther 2016; 7(4): 556-563 [PMID: 27867689 DOI: 10.4292/wjgpt.v7.i4.556] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
218 Pugazhendhi S, Sahu MK, Subramanian V, Pulimood A, Ramakrishna BS. Environmental factors associated with Crohn's disease in India. Indian J Gastroenterol. 2011;30:264-269. [PMID: 22161539 DOI: 10.1007/s12664-011-0145-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
219 Cha JM, Park SH, Rhee KH, Hong SN, Kim YH, Seo SI, Kim KH, Jeong SK, Lee JH, Park SY, Park H, Kim JS, Im JP, Yoon H, Kim SH, Jang J, Kim JH, Suh SO, Kim YK, Ye BD, Yang SK. Long-term prognosis of ulcerative colitis and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea. Gut. 2020;69:1432-1440. [PMID: 31822581 DOI: 10.1136/gutjnl-2019-319699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
220 Hestvik E, Tumwine JK, Tylleskar T, Grahnquist L, Ndeezi G, Kaddu-Mulindwa DH, Aksnes L, Olafsdottir E. Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey. BMC Pediatr 2011;11:9. [PMID: 21284894 DOI: 10.1186/1471-2431-11-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
221 Hovde &, Moum BA. Epidemiology and clinical course of Crohn's disease: Results from observational studies. World J Gastroenterol 2012; 18(15): 1723-1731 [PMID: 22553396 DOI: 10.3748/wjg.v18.i15.1723] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 61] [Article Influence: 8.3] [Reference Citation Analysis]
222 Eaton JE, Juran BD, Atkinson EJ, Schlicht EM, Xie X, de Andrade M, Lammert CS, Luketic VA, Odin JA, Koteish AA, Kowdley KV, Chopra KB, Hirschfield GM, Chalasani NP, Lazaridis KN. A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Aliment Pharmacol Ther 2015;41:980-90. [PMID: 25783671 DOI: 10.1111/apt.13154] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
223 Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease – epidemiology, genetics, and pathogenesis. Expert Review of Gastroenterology & Hepatology 2019;13:307-17. [DOI: 10.1080/17474124.2019.1574569] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 15.0] [Reference Citation Analysis]
224 Kwak MS, Cha JM, Lee HH, Choi YS, Seo SI, Ko KJ, Park DI, Kim SH, Kim TJ. Emerging trends of inflammatory bowel disease in South Korea: A nationwide population-based study. J Gastroenterol Hepatol 2019;34:1018-26. [PMID: 30447025 DOI: 10.1111/jgh.14542] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
225 Zuo T, Yue Y, Wang X, Li H, Yan S. Luteolin Relieved DSS-Induced Colitis in Mice via HMGB1-TLR-NF-κB Signaling Pathway. Inflammation 2021;44:570-9. [PMID: 33015735 DOI: 10.1007/s10753-020-01354-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
226 洪凯, 张翼, 郭媛, 白爱平. 全反式维甲酸治疗葡聚糖硫酸钠诱导的小鼠结肠炎. 世界华人消化杂志 2013; 21(28): 2902-2907 [DOI: 10.11569/wcjd.v21.i28.2902] [Reference Citation Analysis]
227 Zhao J, Ng SC, Lei Y, Yi F, Li J, Yu L, Zou K, Dan Z, Dai M, Ding Y, Song M, Mei Q, Fang X, Liu H, Shi Z, Zhou R, Xia M, Wu Q, Xiong Z, Zhu W, Deng L, Kamm MA, Xia B. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease. Inflamm Bowel Dis 2013;19:1839-45. [PMID: 23669403 DOI: 10.1097/MIB.0b013e31828a6551] [Cited by in Crossref: 13] [Cited by in F6Publishing: 47] [Article Influence: 1.9] [Reference Citation Analysis]
228 Opstelten JL, Leenders M, Dik VK, Chan SS, van Schaik FD, Khaw KT, Luben R, Hallmans G, Karling P, Lindgren S, Grip O, Key TJ, Crowe FL, Boeing H, Bergmann MM, Overvad K, Palli D, Masala G, Racine A, Carbonnel F, Boutron-Ruault MC, Tjønneland A, Olsen A, Andersen V, Kaaks R, Katzke VA, Tumino R, Trichopoulou A, Siersema PD, Bueno-de-Mesquita HB, Hart AR, Oldenburg B. Dairy Products, Dietary Calcium, and Risk of Inflammatory Bowel Disease: Results From a European Prospective Cohort Investigation. Inflamm Bowel Dis 2016;22:1403-11. [PMID: 27120568 DOI: 10.1097/MIB.0000000000000798] [Cited by in Crossref: 47] [Cited by in F6Publishing: 19] [Article Influence: 15.7] [Reference Citation Analysis]
229 Szilagyi A, Leighton H, Burstein B, Xue X. Latitude, sunshine, and human lactase phenotype distributions may contribute to geographic patterns of modern disease: the inflammatory bowel disease model. Clin Epidemiol 2014;6:183-98. [PMID: 24971037 DOI: 10.2147/CLEP.S59838] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
230 Takahashi H, Matsui T, Hisabe T, Hirai F, Takatsu N, Tsurumi K, Kanemitsu T, Sato Y, Kinjyo K, Yano Y, Takaki Y, Nagahama T, Yao K, Washio M. Second peak in the distribution of age at onset of ulcerative colitis in relation to smoking cessation. J Gastroenterol Hepatol. 2014;29:1603-1608. [PMID: 24731020 DOI: 10.1111/jgh.12616] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
231 Sewell JL, Velayos FS. Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness. Inflamm Bowel Dis. 2013;19:627-643. [PMID: 22623078 DOI: 10.1002/ibd.22986] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
232 Uemura R, Fujiwara Y, Iwakura N, Shiba M, Watanabe K, Kamata N, Yamagami H, Tanigawa T, Watanabe T, Tominaga K, Arakawa T. Sleep disturbances in Japanese patients with inflammatory bowel disease and their impact on disease flare. Springerplus 2016;5:1792. [PMID: 27795934 DOI: 10.1186/s40064-016-3408-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
233 Lee HS, Park SH, Yang SK, Kim SO, Soh JS, Lee S, Bae JH, Lee HJ, Yang DH, Kim KJ, Ye BD, Byeon JS, Myung SJ, Kim JH. Appendectomy and the clinical course of ulcerative colitis: a retrospective cohort study and a nested case-control study from Korea. J Gastroenterol Hepatol 2015;30:470-7. [PMID: 25159898 DOI: 10.1111/jgh.12707] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
234 Sato T, Miyawaki T, Katsuno T, Nakagawa T, Inoue M, Watanabe Y, Hishikawa E, Arai M, Yokosuka O. Flicking method: a novel colonoscope insertion method for surveillance colonoscopy in ulcerative colitis patients. Dig Endosc 2012;24:343-7. [PMID: 22925287 DOI: 10.1111/j.1443-1661.2012.01246.x] [Reference Citation Analysis]
235 Seo H, Lee S, So H, Kim D, Kim SO, Soh JS, Bae JH, Lee SH, Hwang SW, Park SH, Yang DH, Kim KJ, Byeon JS, Myung SJ, Yang SK, Ye BD. Temporal trends in the misdiagnosis rates between Crohn’s disease and intestinal tuberculosis. World J Gastroenterol 2017; 23(34): 6306-6314 [PMID: 28974897 DOI: 10.3748/wjg.v23.i34.6306] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
236 Park JJ, Cheon JH, Hong SP, Kim TI, Kim WH. Outcome predictors for thiopurine maintenance therapy in patients with Crohn’s disease. Dig Dis Sci. 2012;57:133-141. [PMID: 22057283 DOI: 10.1007/s10620-011-1955-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
237 Goel A, Dutta AK, Pulimood AB, Eapen A, Chacko A. Clinical profile and predictors of disease behavior and surgery in Indian patients with Crohn’s disease. Indian J Gastroenterol. 2013;32:184-189. [PMID: 23417764 DOI: 10.1007/s12664-012-0293-y,] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
238 周凤, 吴静. 溃疡性结肠炎内科治疗的进展. 世界华人消化杂志 2016; 24(20): 3149-3158 [DOI: 10.11569/wcjd.v24.i20.3149] [Reference Citation Analysis]
239 Weng MT, Tung CC, Chang YT, Leong YL, Wang YT, Wong JM, Wei SC. Trends of Medication Usage and Associated Outcomes for Taiwanese Patients with Inflammatory Bowel Disease from 2001 to 2015. J Clin Med 2018;7:E394. [PMID: 30373275 DOI: 10.3390/jcm7110394] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
240 Jeong SH, Choi JS, Kim JW, Kim HM, Kim HS, Im JP, Kim JS, Kim YS, Cheon JH, Kim WH, Ye BD, Kim YH, Han DS. Clinical Features of Intra-Abdominal Abscess and Intestinal Free-Wall Perforation in Korean Patients with Crohn's Disease: Results from the CONNECT Study. J Clin Med 2020;10:E116. [PMID: 33396251 DOI: 10.3390/jcm10010116] [Reference Citation Analysis]
241 Papoutsopoulou S, Satsangi J, Campbell BJ, Probert CS. Review article: impact of cigarette smoking on intestinal inflammation-direct and indirect mechanisms. Aliment Pharmacol Ther 2020;51:1268-85. [PMID: 32372449 DOI: 10.1111/apt.15774] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
242 Li X, Song P, Li J, Tao Y, Li G, Li X, Yu Z. The Disease Burden and Clinical Characteristics of Inflammatory Bowel Disease in the Chinese Population: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2017;14. [PMID: 28264519 DOI: 10.3390/ijerph14030238] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
243 Song SM, Kim Y, Oh SH, Kim KM. Nutritional status and growth in Korean children with Crohn's disease: a single-center study. Gut Liver 2014;8:500-7. [PMID: 25228974 DOI: 10.5009/gnl13183] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
244 Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621. [PMID: 20192811 DOI: 10.1146/annurev-immunol-030409-101225] [Cited by in Crossref: 1228] [Cited by in F6Publishing: 1209] [Article Influence: 111.6] [Reference Citation Analysis]
245 Gionchetti P, Calabrese C, Tambasco R, Brugnera R, Straforini G, Liguori G, Fornarini GS, Riso D, Campieri M, Rizzello F. Role of conventional therapies in the era of biological treatment in Crohn’s disease. World J Gastroenterol 2011; 17(14): 1797-1806 [PMID: 21528051 DOI: 10.3748/wjg.v17.i14.1797] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
246 Chen W, Fan JH, Luo W, Peng P, Su SB. Effectiveness of interferon-gamma release assays for differentiating intestinal tuberculosis from Crohn’s disease: A meta-analysis. World J Gastroenterol 2013; 19(44): 8133-8140 [PMID: 24307809 DOI: 10.3748/wjg.v19.i44.8133] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
247 Leung WK. Optimization of Inflammatory Bowel Disease Cohort Studies in Asia. Intest Res 2015;13:208-12. [PMID: 26130994 DOI: 10.5217/ir.2015.13.3.208] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
248 Park SC, Jeen YT. Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients. Cells 2019;8:E404. [PMID: 31052430 DOI: 10.3390/cells8050404] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
249 Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015;50:942-951. [PMID: 25687629 DOI: 10.3109/00365521.2015.1014407] [Cited by in Crossref: 186] [Cited by in F6Publishing: 162] [Article Influence: 31.0] [Reference Citation Analysis]
250 Singh B, Kedia S, Konijeti G, Mouli VP, Dhingra R, Kurrey L, Srivastava S, Pradhan R, Makharia G, Ahuja V. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype. Indian J Gastroenterol. 2015;34:43-50. [PMID: 25663290 DOI: 10.1007/s12664-015-0538-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
251 Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM. Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Intest Res. 2017;15:266-284. [PMID: 28670225 DOI: 10.5217/ir.2017.15.3.266] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
252 Ananthakrishnan AN. Debate session: So what causes inflammatory bowel disease? It's all in the environment. J Gastroenterol Hepatol 2018;33 Suppl 3:24. [PMID: 30187567 DOI: 10.1111/jgh.14429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
253 Wan P, Chen H, Guo Y, Bai AP. Advances in treatment of ulcerative colitis with herbs: From bench to bedside. World J Gastroenterol 2014; 20(39): 14099-14104 [PMID: 25339799 DOI: 10.3748/wjg.v20.i39.14099] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
254 Long WY, Chen L, Zhang CL, Nong RM, Lin MJ, Zhan LL, Lv XP. Association between NOD2/CARD15 gene polymorphisms and Crohn's disease in Chinese Zhuang patients. World J Gastroenterol 2014; 20(16): 4737-4744 [PMID: 24782627 DOI: 10.3748/wjg.v20.i16.4737] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
255 Kim JW, Lee CK, Rhee SY, Oh CH, Shim JJ, Kim HJ. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study. J Gastroenterol Hepatol. 2018;33:847-854. [PMID: 29055148 DOI: 10.1111/jgh.14027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
256 Genin M, Duhamel A, Preda C, Fumery M, Savoye G, Peyrin-biroulet L, Salleron J, Lerebours E, Vasseur F, Cortot A, Colombel J, Gower-rousseau C. Space-time clusters of Crohn’s disease in northern France. J Public Health 2013;21:497-504. [DOI: 10.1007/s10389-013-0580-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
257 Zhang H, Dai Y, Liu Y, Wu T, Li J, Wang X, Wang W. Helicobacter pylori Colonization Protects Against Chronic Experimental Colitis by Regulating Th17/Treg Balance. Inflammatory Bowel Diseases 2018;24:1481-92. [DOI: 10.1093/ibd/izy107] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
258 Ha F, Khalil H. Crohn's disease: a clinical update. Therap Adv Gastroenterol. 2015;8:352-359. [PMID: 26557891 DOI: 10.1177/1756283x15592585] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
259 Ye BD, Travis S. Improving the quality of care for inflammatory bowel disease. Intest Res 2019;17:45-53. [PMID: 30449081 DOI: 10.5217/ir.2018.00113] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
260 Shah A, Talley NJ, Walker M, Koloski N, Morrison M, Burger D, Andrews JM, Mcguckin M, Jones M, Holtmann G. Is There a Link Between H. Pylori and the Epidemiology of Crohn’s Disease? Dig Dis Sci 2017;62:2472-80. [DOI: 10.1007/s10620-017-4496-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
261 Ye BD, Yang SK, Cho YK, Park SH, Yang DH, Yoon SM, Kim KJ, Byeon JS, Myung SJ, Yu CS. Clinical features and long-term prognosis of Crohn’s disease in Korea. Scand J Gastroenterol. 2010;45:1178-1185. [PMID: 20560811 DOI: 10.3109/00365521.2010.497936] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 8.1] [Reference Citation Analysis]
262 Shaw SY, Nugent Z, Targownik LE, Singh H, Blanchard JF, Bernstein CN. Association between spring season of birth and Crohn's disease. Clin Gastroenterol Hepatol 2014;12:277-82. [PMID: 23924874 DOI: 10.1016/j.cgh.2013.07.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
263 Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM. Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease. Intest Res 2017;15:285-310. [PMID: 28670226 DOI: 10.5217/ir.2017.15.3.285] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
264 Lin TY, Chen YG, Lin CL, Huang WS, Kao CH. Inflammatory Bowel Disease Increases the Risk of Peripheral Arterial Disease: A Nationwide Cohort Study. Medicine (Baltimore). 2015;94:e2381. [PMID: 26717386 DOI: 10.1097/md.0000000000002381] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
265 Ahuja V, Tandon RK. Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences. J Dig Dis. 2010;11:134-147. [PMID: 20579217 DOI: 10.1111/j.1751-2980.2010.00429.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 112] [Article Influence: 10.3] [Reference Citation Analysis]
266 Hibi T, Imai Y, Senoo A, Ohta K, Ukyo Y. Efficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study). J Gastroenterol 2017;52:1101-11. [PMID: 28324167 DOI: 10.1007/s00535-017-1326-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
267 Yang SS, Yu CS, Yoon YS, Yoon SN, Lim SB, Kim JC. Risk factors for complications after bowel surgery in Korean patients with Crohn's disease. J Korean Surg Soc 2012;83:141-8. [PMID: 22977760 DOI: 10.4174/jkss.2012.83.3.141] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
268 Lakatos PL. Use of new once-daily 5-aminosalicylic acid preparations in the treatment of ulcerative colitis: Is there anything new under the sun? World J Gastroenterol 2009; 15(15): 1799-1804 [PMID: 19370774 DOI: 10.3748/wjg.15.1799] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
269 Wang YF, Ouyang Q, Hu RW. Progression of inflammatory bowel disease in China. J Dig Dis. 2010;11:76-82. [PMID: 20402832 DOI: 10.1111/j.1751-2980.2010.00421.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 5.4] [Reference Citation Analysis]
270 Park YE, Park Y, Park SJ, Kim TI, Kim WH, Kim JN, Lee NR, Cheon JH. Is fasting beneficial for hospitalized patients with inflammatory bowel diseases? Intest Res 2020;18:85-95. [PMID: 31308352 DOI: 10.5217/ir.2019.00055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
271 Yu Y, Zhu S, Li P, Min L, Zhang S. Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract. Cell Death Dis 2018;9:961. [PMID: 30237392 DOI: 10.1038/s41419-018-0982-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
272 Cheon JH, Kim YS, Ye BD, Lee KM, Kim YH, Kim JS, Han DS, Kim WH. Crohn's Disease Clinical Network and Cohort (CONNECT) Study: The First Step Toward Nationwide Multicenter Research of Crohn's Disease in Korea. Intest Res 2014;12:173-5. [PMID: 25349589 DOI: 10.5217/ir.2014.12.3.173] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
273 易金霞, 费素娟, 庞迅雷, 吴克俭. 姜黄素联合MSCs对大鼠溃疡性结肠炎的影响及机制. 世界华人消化杂志 2014; 22(12): 1642-1650 [DOI: 10.11569/wcjd.v22.i12.1642] [Reference Citation Analysis]
274 Martínez-Montiel MDP, Gómez-Gómez GJ, Flores AI. Therapy with stem cells in inflammatory bowel disease. World J Gastroenterol 2014; 20(5): 1211-1227 [PMID: 24574796 DOI: 10.3748/wjg.v20.i5.1211] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
275 Taheri M, Ghandil P, Hashemi SJ, Ghafourian M, Masjedi Zadeh AR, Ghadiri AA. Association study between two polymorphisms of tumor necrosis factor ligand superfamily member 15 (TNFSF15) gene and ulcerative colitis in south-west of Iran. J Cell Biochem 2018. [PMID: 30556168 DOI: 10.1002/jcb.28165] [Reference Citation Analysis]
276 Lee JW, Choi CH, Park JH, Kim JW, Kang SB, Koo JS, Kim YH, Kim YS, Joo YE, Chang SK. Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease. Intest Res 2016;14:146-51. [PMID: 27175115 DOI: 10.5217/ir.2016.14.2.146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
277 Yang S, Jung Y, Hong M, Kim H, Ye BD, Lee I, Song K. No association between TNFSF15 and IL23R with ulcerative colitis in Koreans. J Hum Genet 2011;56:200-4. [DOI: 10.1038/jhg.2010.166] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
278 Wang H, Liu JS, Peng SH, Deng XY, Zhu DM, Javidiparsijani S, Wang GR, Li DQ, Li LX, Wang YC, Luo JM. Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases. World J Gastroenterol 2013; 19(40): 6794-6804 [PMID: 24187454 DOI: 10.3748/wjg.v19.i40.6794] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
279 Jukic A, Bakiri L, Wagner EF, Tilg H, Adolph TE. Calprotectin: from biomarker to biological function. Gut 2021:gutjnl-2021-324855. [PMID: 34145045 DOI: 10.1136/gutjnl-2021-324855] [Reference Citation Analysis]
280 Garlatti V, Lovisa S, Danese S, Vetrano S. The Multiple Faces of Integrin-ECM Interactions in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:10439. [PMID: 34638778 DOI: 10.3390/ijms221910439] [Reference Citation Analysis]
281 Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV, Tysk C, O’Morain C, Moum B, Colombel JF. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62:630-649. [PMID: 23335431 DOI: 10.1007/s11894-013-0313-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
282 Lin HC, Chiu CC, Chen SF, Lou HY, Chiu WT, Chen YH. Ulcerative colitis and pregnancy outcomes in an Asian population. Am J Gastroenterol. 2010;105:387-394. [PMID: 19809415 DOI: 10.1038/ajg.2009.562] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
283 Eun CS, Kwak MJ, Han DS, Lee AR, Park DI, Yang SK, Kim YS, Kim JF. Does the intestinal microbial community of Korean Crohn's disease patients differ from that of western patients? BMC Gastroenterol 2016;16:28. [PMID: 26922889 DOI: 10.1186/s12876-016-0437-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
284 Hermon-Taylor J. Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario. Gut Pathog 2009;1:15. [PMID: 19602288 DOI: 10.1186/1757-4749-1-15] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 5.3] [Reference Citation Analysis]
285 Li D, Collins B, Velayos FS, Liu L, Lewis JD, Allison JE, Flowers NT, Hutfless S, Abramson O, Herrinton LJ. Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization. Dig Dis Sci 2014;59:287-94. [PMID: 24173809 DOI: 10.1007/s10620-013-2908-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
286 Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis. 2010;16:1077-1084. [PMID: 19760778 DOI: 10.1002/ibd.21116] [Cited by in Crossref: 137] [Cited by in F6Publishing: 138] [Article Influence: 12.5] [Reference Citation Analysis]
287 Rokkas T, Gisbert JP, Niv Y, O'Morain C. The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis. United European Gastroenterol J. 2015;3:539-550. [PMID: 26668747 DOI: 10.1177/2050640615580889] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
288 Wilson J, Hair C, Knight R, Catto-Smith A, Bell S, Kamm M, Desmond P, McNeil J, Connell W. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm Bowel Dis. 2010;16:1550-1556. [PMID: 20803698 DOI: 10.1002/ibd.21209] [Cited by in Crossref: 115] [Cited by in F6Publishing: 98] [Article Influence: 10.5] [Reference Citation Analysis]
289 Lee HS, Oh H, Yang SK, Baek J, Jung S, Hong M, Kim KM, Shin HD, Kim KJ, Park SH, Ye BD, Han B, Song K. X Chromosome-wide Association Study Identifies a Susceptibility Locus for Inflammatory Bowel Disease in Koreans. J Crohns Colitis 2017;11:820-30. [PMID: 28333213 DOI: 10.1093/ecco-jcc/jjx023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
290 Kee BP, Ng JG, Ng CC, Hilmi I, Goh KL, Chua KH. Genetic polymorphisms of ATG16L1 and IRGM genes in Malaysian patients with Crohn's disease. J Dig Dis 2020;21:29-37. [PMID: 31654602 DOI: 10.1111/1751-2980.12829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
291 Chang CW, Wei SC, Chou JW, Hsu TC, Chuang CH, Lin CP, Hsu WH, Yen HH, Lin JK, Fang YJ, Wang HY, Lin HH, Wu DC, Ni YH, Wang CY, Wong JM. Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study. Intest Res 2014;12:287-92. [PMID: 25374494 DOI: 10.5217/ir.2014.12.4.287] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
292 Schirbel A, Fiocchi C. Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis. 2010;11:266-276. [PMID: 20883422 DOI: 10.1111/j.1751-2980.2010.00449.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 7.7] [Reference Citation Analysis]
293 Kuo CJ, Yu KH, See LC, Chiu CT, Su MY, Hsu CM, Kuo CF, Chiou MJ, Liu JR, Wang HW. The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study. Dig Dis Sci. 2015;60:2454-2462. [PMID: 25837597 DOI: 10.1007/s10620-015-3630-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
294 Carpio D, Barreiro-de Acosta M, Echarri A, Pereira S, Castro J, Ferreiro R, Lorenzo A. Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study. European Journal of Gastroenterology & Hepatology 2015;27:1030-7. [DOI: 10.1097/meg.0000000000000395] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
295 Kim H, Im JP, Kim JS, Kang JS, Lee WJ. Alloferon Alleviates Dextran Sulfate Sodium-induced Colitis. Immune Netw 2015;15:135-41. [PMID: 26140045 DOI: 10.4110/in.2015.15.3.135] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
296 Yang SK, Kim H, Hong M, Lim J, Choi E, Ye BD, Park SK, Song K. Association of CARD8 with inflammatory bowel disease in Koreans. J Hum Genet 2011;56:217-23. [PMID: 21248762 DOI: 10.1038/jhg.2010.170] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
297 Barash Y, Klang E, Tau N, Ben-Horin S, Mahajna H, Levartovsky A, Arebi N, Soffer S, Kopylov U. Evolution of Inflammatory Bowel Disease Research From a Bird's-Eye Perspective: A Text-Mining Analysis of Publication Trends and Topics. Inflamm Bowel Dis 2021;27:434-9. [PMID: 32440691 DOI: 10.1093/ibd/izaa091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
298 Jung YS, Han M, Kim WH, Park S, Cheon JH. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study. Dig Dis Sci. 2017;62:2102-2112. [PMID: 28593437 DOI: 10.1007/s10620-017-4640-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
299 Laing BB, Lim AG, Ferguson LR. A Personalised Dietary Approach-A Way Forward to Manage Nutrient Deficiency, Effects of the Western Diet, and Food Intolerances in Inflammatory Bowel Disease. Nutrients 2019;11:E1532. [PMID: 31284450 DOI: 10.3390/nu11071532] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
300 Yoon YS, Yu CS, Yang SK, Yoon SN, Lim SB, Kim JC. Intra-abdominal fistulas in surgically treated Crohn's disease patients. World J Surg 2010;34:1924-9. [PMID: 20372893 DOI: 10.1007/s00268-010-0568-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
301 Chandan JS, Thomas T. The impact of inflammatory bowel disease on oral health. Br Dent J 2017;222:549-53. [PMID: 28387295 DOI: 10.1038/sj.bdj.2017.318] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
302 Al-Qabandi WA, Buhamrah EK, Hamadi KA, Al-Osaimi SA, Al-Ruwayeh AA, Madda J. Inflammatory bowel disease in children, an evolving problem in Kuwait. Saudi J Gastroenterol. 2011;17:323-327. [PMID: 21912059 DOI: 10.4103/1319-3767.84487] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
303 Nguyen DL, Limketkai B, Medici V, Saire Mendoza M, Palmer L, Bechtold M. Nutritional Strategies in the Management of Adult Patients with Inflammatory Bowel Disease: Dietary Considerations from Active Disease to Disease Remission. Curr Gastroenterol Rep 2016;18:55. [PMID: 27637649 DOI: 10.1007/s11894-016-0527-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
304 Niriella MA, De Silva AP, Dayaratne AH, Ariyasinghe MH, Navarathne MM, Peiris RS, Samarasekara DN, Satharasinghe RL, Rajindrajith S, Dassanayake AS, Wickramasinghe AR, de Silva HJ. Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based survey. BMC Gastroenterol 2010;10:32. [PMID: 20302651 DOI: 10.1186/1471-230X-10-32] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
305 M’koma A. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. GastrointestDisord 2018;1:75-105. [DOI: 10.3390/gidisord1010007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
306 Leong RWL, Kamm MA, Hu PJ, Sung JJY. Inflammatory bowel disease in Asia: Editorials. Journal of Gastroenterology and Hepatology 2010;25:436-8. [DOI: 10.1111/j.1440-1746.2010.06256.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
307 Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. Ambient air pollution correlates with hospitalizations for inflammatory bowel disease: an ecologic analysis. Inflamm Bowel Dis. 2011;17:1138-1145. [PMID: 20806342 DOI: 10.1002/ibd.21455] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 7.3] [Reference Citation Analysis]
308 Han DS. Current status and prospects of intestinal microbiome studies. Intest Res 2014;12:178-83. [PMID: 25349591 DOI: 10.5217/ir.2014.12.3.178] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
309 Han B, Akiyama M, Kim KK, Oh H, Choi H, Lee CH, Jung S, Lee HS, Kim EE, Cook S, Haritunians T, Yamazaki K, Park SH, Ye BD, McGovern DPB, Esaki M, Kawaguchi T, Khor SS, Taylor KD, Rotter JI, Suzuki Y, Matsui T, Motoya S, Bang SY, Kim TH, Momozawa Y, Kamatani Y, Tokunaga K, Kubo M, Okada Y, Yang SK, Song K. Amino acid position 37 of HLA-DRβ1 affects susceptibility to Crohn's disease in Asians. Hum Mol Genet 2018;27:3901-10. [PMID: 30084967 DOI: 10.1093/hmg/ddy285] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
310 Agarwala R, Singh AK, Shah J, Mandavdhare HS, Sharma V. Ileocecal thickening: Clinical approach to a common problem. JGH Open 2019;3:456-63. [PMID: 31832544 DOI: 10.1002/jgh3.12186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
311 Park JJ, Yang SK, Ye BD, Kim JW, Park DI, Yoon H, Im JP, Lee KM, Yoon SN, Lee H; IBD Study Group of the Korean Association for the Study of the Intestinal Diseases. [Second Korean Guidelines for the Management of Crohn's Disease]. Korean J Gastroenterol 2017;69:29-54. [PMID: 28135790 DOI: 10.4166/kjg.2017.69.1.29] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
312 Cheon JH. Genetics of inflammatory bowel diseases: A comparison between Western and Eastern perspectives: Genetics of inflammatory bowel diseases. J Gastroenterol Hepatol 2013;28:220-6. [DOI: 10.1111/jgh.12053] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
313 Kim BJ, Choi YS, Jang BI, Park YS, Kim WH, Kim YS, Jung SA, Han DS, Kim JS, Choi JH. Prospective evaluation of the clinical utility of interferon-γ assay in the differential diagnosis of intestinal tuberculosis and Crohn’s disease. Inflamm Bowel Dis. 2011;17:1308-1313. [PMID: 21053248 DOI: 10.1002/ibd.21490] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
314 Anzai H, Hata K, Kishikawa J, Ishii H, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Nozawa H, Kazama S, Yamaguchi H, Ishihara S, Sunami E, Kitayama J, Watanabe T. Clinical pattern and progression of ulcerative proctitis in the Japanese population: a retrospective study of incidence and risk factors influencing progression. Colorectal Dis 2016;18:O97-O102. [DOI: 10.1111/codi.13237] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
315 Kakodkar S, Mutlu EA. Diet as a Therapeutic Option for Adult Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2017;46:745-767. [PMID: 29173519 DOI: 10.1016/j.gtc.2017.08.016] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 13.7] [Reference Citation Analysis]
316 Kim OZ, Han DS, Park CH, Eun CS, Kim YS, Kim YH, Cheon JH, Ye BD, Kim JS. The Clinical Characteristics and Prognosis of Crohn's Disease in Korean Patients Showing Proximal Small Bowel Involvement: Results from the CONNECT Study. Gut Liver. 2018;12:67-72. [PMID: 28798284 DOI: 10.5009/gnl16500] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
317 Choi JK, Kim DW, Shin SY, Park EC, Kang JG. Effect of Ulcerative Colitis on Incidence of Colorectal Cancer: Results from the Nationwide Population-Based Cohort Study (2003-2013). J Cancer 2016;7:681-6. [PMID: 27076849 DOI: 10.7150/jca.14264] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
318 Ng SC, Tang W, Leong RW, Chen M, Ko Y, Studd C, Niewiadomski O, Bell S, Kamm MA, de Silva HJ, Kasturiratne A, Senanayake YU, Ooi CJ, Ling KL, Ong D, Goh KL, Hilmi I, Ouyang Q, Wang YF, Hu P, Zhu Z, Zeng Z, Wu K, Wang X, Xia B, Li J, Pisespongsa P, Manatsathit S, Aniwan S, Simadibrata M, Abdullah M, Tsang SW, Wong TC, Hui AJ, Chow CM, Yu HH, Li MF, Ng KK, Ching J, Wu JC, Chan FK, Sung JJ; Asia-Pacific Crohn's and Colitis Epidemiology Study ACCESS Group. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut. 2015;64:1063-1071. [PMID: 25217388 DOI: 10.1136/gutjnl-2014-307410] [Cited by in Crossref: 179] [Cited by in F6Publishing: 168] [Article Influence: 25.6] [Reference Citation Analysis]
319 Prideaux L, Kamm MA, De Cruz P, Williams J, Bell SJ, Connell WR, Brown SJ, Lust M, Desmond PV, Chan H. Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne. J Gastroenterol Hepatol. 2012;27:919-927. [PMID: 22098103 DOI: 10.1111/j.1440-1746.2011.06984.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
320 牛俊坤, 缪应雷. 内镜在溃疡性结肠炎诊治中的作用. 世界华人消化杂志 2011; 19(20): 2153-2159 [DOI: 10.11569/wcjd.v19.i20.2153] [Reference Citation Analysis]
321 Ye BD, Yang SK, Shin SJ, Lee KM, Jang BI, Cheon JH, Choi CH, Kim YH, Lee H. [Guidelines for the management of Crohn’s disease]. Korean J Gastroenterol. 2012;59:141-179. [PMID: 22387837 DOI: 10.4166/kjg.2012.59.2.141] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
322 Logan I, Bowlus CL. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev. 2010;9:A372-A378. [PMID: 19903540 DOI: 10.1016/j.autrev.2009.11.008] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 6.8] [Reference Citation Analysis]
323 Abdul Rani R, Raja Ali RA, Lee YY. Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place. Intest Res 2016;14:297-304. [PMID: 27799880 DOI: 10.5217/ir.2016.14.4.297] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
324 Mahurkar S, Banerjee R, Rani VS, Thakur N, Rao GV, Reddy DN, Chandak GR. Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians. J Gastroenterol Hepatol. 2011;26:694-699. [PMID: 21155887 DOI: 10.1111/j.1440-1746.2010.06533.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
325 Ye BD, Yang S, Shin SJ, Lee KM, Jang BI, Cheon JH, Choi CH, Kim Y, Lee H; IBD Study Group of the Korean Association for the Study of the Intestinal Diseases. Guidelines for the Management of Crohn's Disease. Intest Res 2012;10:26. [DOI: 10.5217/ir.2012.10.1.26] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
326 So H, Ye BD, Park YS, Kim J, Kim JS, Moon W, Lee KM, Kim YS, Keum B, Kim SE. Gastric lesions in patients with Crohn’s disease in Korea: a multicenter study. Intest Res. 2016;14:60-68. [PMID: 26884736 DOI: 10.5217/ir.2016.14.1.60] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
327 Islami F, Ferlay J, Lortet-Tieulent J, Bray F, Jemal A. International trends in anal cancer incidence rates. Int J Epidemiol 2017;46:924-38. [PMID: 27789668 DOI: 10.1093/ije/dyw276] [Cited by in Crossref: 33] [Cited by in F6Publishing: 57] [Article Influence: 11.0] [Reference Citation Analysis]
328 Jeong SY, Moon JS, Park KJ, Kim YS. Successful treatment of postoperative fistula with infliximab in a patient with Crohn's disease. Intest Res 2014;12:74-7. [PMID: 25349568 DOI: 10.5217/ir.2014.12.1.74] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
329 Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205-217. [PMID: 25732745 DOI: 10.1038/nrgastro.2015.34] [Cited by in Crossref: 662] [Cited by in F6Publishing: 594] [Article Influence: 110.3] [Reference Citation Analysis]
330 Hong T, Yang Z, Lv CF, Zhang Y. Suppressive effect of berberine on experimental dextran sulfate sodium-induced colitis. Immunopharmacol Immunotoxicol. 2012;34:391-397. [PMID: 22564173 DOI: 10.3109/08923973.2011.609887] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
331 Cooper PJ. Mucosal immunology of geohelminth infections in humans. Mucosal Immunol 2009;2:288-99. [PMID: 19404245 DOI: 10.1038/mi.2009.14] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
332 Park SJ, Kim WH, Cheon JH. Clinical characteristics and treatment of inflammatory bowel disease: A comparison of Eastern and Western perspectives. World J Gastroenterol 2014; 20(33): 11525-11537 [PMID: 25206259 DOI: 10.3748/wjg.v20.i33.11525] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 65] [Article Influence: 9.4] [Reference Citation Analysis]
333 Jeuring SF, van den Heuvel TR, Zeegers MP, Hameeteman WH, Romberg-Camps MJ, Oostenbrug LE, Masclee AA, Jonkers DM, Pierik MJ. Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity? Inflamm Bowel Dis 2016;22:1425-34. [PMID: 26933752 DOI: 10.1097/MIB.0000000000000738] [Cited by in Crossref: 70] [Cited by in F6Publishing: 23] [Article Influence: 23.3] [Reference Citation Analysis]
334 Esmat S, El Nady M, Elfekki M, Elsherif Y, Naga M. Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt. World J Gastroenterol 2014; 20(3): 814-821 [PMID: 24574754 DOI: 10.3748/wjg.v20.i3.814] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
335 Riddle MS, Murray JA, Porter CK. The incidence and risk of celiac disease in a healthy US adult population. Am J Gastroenterol. 2012;107:1248-1255. [PMID: 22584218 DOI: 10.1038/ajg.2012.130] [Cited by in Crossref: 70] [Cited by in F6Publishing: 51] [Article Influence: 7.8] [Reference Citation Analysis]
336 Hong M, Ye BD, Yang SK, Jung S, Lee HS, Kim BM, Lee SB, Hong J, Baek J, Park SH, Han B, Li Y, Liu W, Haritunians T, Taylor KD, Rotter JI, Bang SY, Kim TH, McGovern DPB, Liu J, Song K. Immunochip Meta-Analysis of Inflammatory Bowel Disease Identifies Three Novel Loci and Four Novel Associations in Previously Reported Loci. J Crohns Colitis 2018;12:730-41. [PMID: 29584801 DOI: 10.1093/ecco-jcc/jjy002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
337 Xu W, Guo Y, Huang Z, Zhao H, Zhou M, Huang Y, Wen D, Song J, Zhu Z, Sun M, Liu C, Chen Y, Cui L, Wang X, Liu Z, Yang Y, Du P. Small heat shock protein CRYAB inhibits intestinal mucosal inflammatory responses and protects barrier integrity through suppressing IKKβ activity. Mucosal Immunol 2019;12:1291-303. [DOI: 10.1038/s41385-019-0198-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
338 Melum E, Franke A, Karlsen TH. Genome-wide association studies - A summary for the clinical gastroenterologist. World J Gastroenterol 2009; 15(43): 5377-5396 [PMID: 19916168 DOI: 10.3748/wjg.15.5377] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
339 Chen CY, Lee KT, Charles Tzu-Chi L, Lai WT, Huang YB. Epidemiology and Disease Burden of Ulcerative Colitis in Taiwan: A Nationwide Population-Based Study. Value Health Reg Issues 2013;2:127-34. [PMID: 29702840 DOI: 10.1016/j.vhri.2013.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]